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General introduction 
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1. Preface 
This thesis deals with the controversies in both microscopic and 
automated blood cell morphology. Since Anthony van Leeuwenhoek 
discovered blood cells with his newly discovered microscope, blood cell 
differentiation is a world wide accepted diagnosticum, and has developed 
to full-automated recognition of blood cells nowadays (figure 1).  
In this thesis we describe some controversial morphologic features of 
various cells and we offer alternatives. Particularly, with respect to sepsis 
diagnosis. In some cases, a microscopic observation of blood smears is 
necessary and may lead to a better understanding of haematology 
analysers and their automated differentials.  
 
 
 
  
fig 1 
a Van Leeuwenhoek’s  microscope 
 
b Fully automated microscope DM96 of 
Sysmex 
 
 
 
2. Differentiation of blood cells 
In one litre human blood 3 to 5 trillion red blood cells, 4.5 to 12 billion 
white blood cells and 120 to 350 billion platelets circulate. To diagnose 
various diseases, e.g. anaemia, infection, or bleeding disorders, these 
cells are counted using automated analysers. In addition, a blood smear 
can be made to analyse morphologic features of the cells in case of 
diseases as haemoglobin-, neoplastic- or platelet disorders. 
Differentiation of white blood cells plays an important role in diagnosis 
and follow-up of various haematological and non-haematological 
diseases. Therefore a large number of differentials are requested daily in 
laboratory medicine[1]. In the blood, mature cells are circulating which are 
released from the bone marrow. Five major white cell populations can be 
distinguished: monocytes, lymphocytes, segmented neutrophils, 
eosinophils, and basophils. The composition and/or the number of these 
cells can be indicative for various diseases. In order to analyse these 
cells microscopically, blood smears have to be made and stained to 
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distinguish the different cells. Worldwide two staining methods are used: 
Wright staining and May-Grünwald Giemsa staining. Both methods 
enable to differentiate white blood cells based on size, nuclear shape 
and density, cytoplasmic colouring and granularity. For routine 
microscopic differentiation of white blood cells one hundred cells are 
differentiated and reported as percentage and/or absolute counts. 
Nowadays, instead of micrsocopic differentiation automated differentials 
are used. Automated differentials are based on flow cytometry, 
impedance technique or cytochemistry. Abnormalities may be 
recognised by automated analysers and flagged for. Microscopic control 
is than often necessary. 
 
  
fig 2 
a lymphocyte 
 
b neutrophil 
 
c eosinophil 
 
d basophil 
 
e monocyte 
 
 
2.1 Microscopy 
To identify different subtypes of leukocytes routine stains are used 
(figure 2). The most frequently used staining methods are the May-
Grünwald Giemsa staining and the Wright staining method. With these 
staining methods blood cells can be differentiated into neutrophils, 
lymphocytes, monocytes, eosinophils, basophils and their precursor 
cells. Moreover, platelets can be recognized and erythrocytes can be 
observed and checked for abnormalities. 
For specific cell details and subclassifications other staining methods 
were developed e.g. peroxidase-, PAS- and sudan black staining. In the 
present time, flow cytometry is used to substitute these methods 
because of their sensitivity and specificity[2]. 
Enumeration and proportion of cell types can attribute to the diagnosis of 
several diseases. Nevertheless, differentiation of 100 or 200 cells have 
large sample variance. Moreover, quality of the blood smears and 
expertise of the observer play a major role in the reliance of the final 
result[3]. Despite these limitations, this method is still used as the golden 
standard[4, 5], while some abnormalities are not recognized by automated 
haematology analysers, even in some cases no flagging appear at all, 
e.g. the presence of a small amount of malaria parasites or bacteria. In 
Chapter two the presence of bacteria in blood smears is described. 
Normally the presence of bacteria in blood is demonstrated by 
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conventional blood cultures. However these results are often only 
available after several days. Sometimes bacteria are seen in routinely 
obtained blood smears and become sufficiently numerous to be identified 
in the terminal phase of an overwhelming sepsis[6-8]. The finding of 
intracellular bacteria in routine blood smears prepared from a blood 
sample taken from a central venous catheter (CVC) most likely indicates 
catheter related infections[6, 9-11]. Blood samples obtained by finger or 
heel prick may contain bacteria or fungi as a consequence of in vitro 
contamination. In these situations bacteria will only be present 
extracellularly. However, if a long period has elapsed from the time of the 
puncture to the moment of preparing the blood smear, phagocytosis by 
neutrophils may lead to intracellular bacteria. The finding of bacteria in 
blood smears may result in the identification of a severe sepsis, CVC 
related infection or an in vitro contamination. These findings indicate that 
microscopy may contribute to a fast diagnosis of overwhelming sepsis 
not yet determined by blood cultures[6, 12, 13]. 
 
 
2.2  Automated differentials 
Over the past 30 years, continuing technology in cell counting and 
differentiation has challenged the microscopic differentials[14]. The current 
automated analysers are capable of providing multiparameter, white 
blood cell, red blood cell and platelet parameters. In the beginning of the 
seventies automated image processing were developed by several 
manufacturers (e.g. Corning, Abbott and Sysmex), and were based on 
imaging recognition software. The Hemalog D (Technicon), cell counting 
and differentials were combined. Elaborating the Hemalog D analyser 
several other manufacturers developed machines[15]. The next 
generation automated haematology analysers generated full blood cell 
counts, including a five-part differential. The used techniques varied form 
impedance, flow cytometry to peroxidase staining, or a combination of 
these methods[16-20]. Refinement of the technique resulted in compact 
automated instruments, which generated a full blood cell count including 
differentials and reticulocytes with additional parameters such as 
nucleated red blood cells[21-25]. Instruments can be linked to a full 
automated ‘street‘, including an automated slide maker and stainer. 
Methods are developed to add cell indices such as immature 
granulocytes, reticulated platelets, reticulocyte haemoglobin [26-29]. Even 
monoclonal antibodies can be used on a routine haematology analyser[30, 
31]. 
The first automated analysers were able to detect abnormal cell 
populations and flagged for these abnormalities. Using these flaggings 
the number of microscopic differentials could be dramatically reduced. 
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However, these flaggings seemed to have poor sensitivity and 
specificity[32]. Chapter 3 describes the overestimation of abnormalities 
based on these flaggings. And, even worser, some abnormalities are not 
accompanied by flagging messages at all (e.g. bacteraemia, malaria; 
figure 3). 
  
 
 
 
 
fig 3 
Intracellular malaria parasites 
However, traditional microscopy will continue to be used in routine 
haematology in combination with automated image recognition systems. 
Further advances in the technology of automated image recognition 
systems can be expected to create new challenges for the blood cell 
image interpretation[15]. 
 
 
2.3 Band cells 
Upon activation of neutrophils, band cells (figure 4) appear in the 
circulation. Therefore enumeration of band cells is ingrained in clinical 
practice[33]. Although the descriptive definition of a band cell is well 
documented[34-36], the ability of individual laboratory technicians to 
interpret and apply these descriptive guidelines consistently is actually 
quite poor[37]. In addition to band cells, immature granulocytes defined as 
metamyelocytes and myelocytes, may be seen. Modern haematology 
analysers are able to generate automated five-part differentials 
(expressed in relative as well as absolute counts) and resolve many of 
the statistical limitations of the microscopic differential[14, 16]. Technical 
improvements have lead to expansion of the morphological subtypes of 
cell classes e.g. immature granulocytes[26] that can be recognized. 
Moreover, the general reliability of automated leukocyte differentials has 
significantly reduced conventional microscopic reviews. Flagging for 
morphological abnormalities, however, still has little sensitivity[32]. 
Therefore, flagging for abnormalities may lead to overestimation of the 
number of abnormalities. 
Due to this statistical unreliability and the poor diagnostic value of the 
enumeration of band cells, new diagnostic tools have been developed to 
detect sepsis, such as expression of proteins and interleukins[38]. 
 5
chapter 1 
 
fig 4 
a) Segmented neutrophil, b) controversial band cell, c) band cell 
 
 
2.4 Atypical lymphocytes 
The classification of lymphocyte disorders is complex because of the 
various manifestations of these disorders[39, 40]. Roughly three major 
populations can be distinguished: reactive lymphocytosis, premalignant 
neoplastic disorders and neoplastic disorders of lymphocytes[5]. 
Lymphocyte disorders can be accompanied by abnormal lymphocyte 
morphology. It is therefore of utmost importance to recognize abnormal 
lymphocytes, such as atypical lymphocytes and lymphoblasts. However, 
the ability of individual laboratory technicians to interpret abnormal 
lymphocytes consistently is quite poor. There are no standardised 
definitions and interpretation is based on subjectivity and depends on 
additional clinical information. Abnormal lymphocytes also can contribute 
to a quick diagnosis of various diseases, like viral infections and 
leukaemia, but must be interpreted with care. Some rare diseases are  
 
 
 
   
Lymphocyte Lymphocyte Atypical 
lymphocyte 
Atypical 
lymphocyte 
 
 
   
Plasma cell Plasma cell Blast Blast 
fig 5 
Morphology of lymphocytes 
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accompanied with atypical lymphocytes. For I-cell disease, inclusion 
bodies are formed by accumulated macromolecules due to multiple 
lysosomal enzyme deficiencies, these are seen as vacuole like 
inclusions[41-43]. 
The problem to classify subtypes of lymphocytes gives us the opportunity 
to make two steps; microscopic classification of lymphocytes should be 
standardised and variant (or suspicious) lymphocytes (figure 5) should 
be evaluated by expert blood cell morphology. 
 
 
2.5 Platelets 
The number of platelets is related to the bleeding risks and therefore an 
important parameter for pre-operative screening and diagnosis. For 
microscopic platelet counting a counting chamber is used and platelets 
can be counted using the microscope phase contrast technique. This 
manual technique, however, is imprecise and time consuming especially 
when the platelet count is low[44]. The automated counting of platelets is 
now the rule rather than the exception, because automated platelet 
counting is precise and in a short time a lot of cells can be counted. 
However, spurious platelet counts are observed in pseudo 
thrombocytosis, and pseudo thrombocytopenia. 
The use of anticoagulans can cause pseudo thrombocytopenia[45-47], 
which is not recognized by the automated platelet counting, while 
microscopic examination of the blood shows aggregated platelets. 
Another way of blood sampling is necessary to obtain a correct platelet 
count[48]. Also giant platelets may interfere with red blood cells and can 
therefore be counted as red blood cells and not as platelets[49]. 
A spurious thrombocytosis can be caused by the presence of 
pseudoplatelets[50], cryoglobulins[51] and bacteria[52]. Small vesicles 
mimicking platelets, originated from leukocytes, may appear when 
sepsis[50] or malignant disorders[53] are present. Acute leukaemias often 
are accompanied with haemorrhagic diathesis, which may be caused by 
thrombocytopenia[54]. In such patients, a spurious platelet count due to 
fragmentation of white blood cells has been reported[55-57]. Staining blood 
smears of a patient suffering from acute leukaemia with a normal platelet 
count, using platelet-specific antigen resulted in 4% positive cells, 
whereas one third part of the particles showed staining characteristics 
identical to the leukaemia cells. These results point to the leukaemic 
origin of the pseudoplatelets[55]. Recognition of pseudoplatelets in this 
group of patients is very important because of the risk of bleeding (figure 
6). 
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Normal platelets 
 
Pseudoplatelets Macrocytic platelets Agranular platelets 
 
 
 
Platelet aggregates Platelet satellitism 
fig 6 
Morphology of platelets 
 
Cryoglobins may cause an erroneous platelet count because their size 
may be equal to platelets[51]. In these cases immuno platelet counting 
should be performed. When bacteria are present in small numbers in 
peripheral blood, a delay in the processing of the blood sample may 
cause increment in the number of bacteria. These bacteria also can 
interfere with platelet counting[52].  
One should be aware that in many cases platelet sized particles could 
lead to a spurious elevated platelet count. Microscopic examination of 
the blood smear may track suspicious cases, and immuno platelet 
counting using anti-CD61 may be an alternative to report a correct 
platelet count[58]. 
As mentioned before presence of platelet-sized particles may lead to 
falsely elevated platelet counts. In spite of the fact that platelet counts 
are performed using impedance techniques or flow cytometry on a 
routine analyser these platelet-sized particles may be not recognized. 
Microscopic counting in a counting chamber is not an alternative since 
this method is also based on particle size. Observation of a stained blood 
smear is the only way to detect the so-called pseudoplatelets. Counting 
platelets using antibodies in combination with flow cytometry should lead 
to an accurate platelet count. 
 
 
3 Alternative diagnostics for sepsis 
Infection can lead to sepsis, which can ultimately cause septic shock. As 
mortality increases during the development of septic shock, early 
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detection of sepsis is very important. Infection and sepsis can be 
accompanied by various abnormalities in blood cells, both quantitatively 
and morphologically. A reaction on infection is an increase of the 
neutrophils (neutrophilia), or a decrease of neutrophils (neutropenia) due 
to consumption. Often, infection is accompanied by toxic granulation 
and/or vacuolisation of the white blood cells. Immature granulocytes may 
appear such as band cells and metamyelocytes. Because of the 
diagnostic and statistic limitations of cell morphology, alternative 
diagnostic tests have been developed[59-61]. 
Other than haematological parameters have been developed to diagnose 
infection or sepsis, such as the measurement of C-reactive protein 
(CRP). CRP has its limitations[62, 63], white blood cell differentiation is still 
extensively used for evaluation of infection or sepsis. Right now we are 
at a turning point with respect to sepsis diagnosis. Interleukins and cell 
surface markers gain ground and seem to be more specific. An important 
drawback of these tests, however, is the high price per test. 
 
 
3.1 Immature granulocytes 
Immature granulocytes appear as a result of the release of premature 
cells from the bone marrow, caused by cytokine stimulation, and may 
therefore be a sign for infection[64]. Compared to enumeration of band 
cells, counting of immature granulocytes is less controversial, and may 
be a good discriminator between infected and non-infected patients[65]. 
Using special developed software, the Sysmex XE-2100 haematology 
analyser is capable of counting immature granulocytes in an accurate 
and relative easy way[26]. Based on a combination of fluorescent staining 
and sideward scatter signals, immature granulocytes can be separated 
from mature granulocytes.  
 
 
3.2  CD64 
Apart from changes in neutrophils and their precursors, cell surface 
markers (CD markers) can change and might therefore be used as a 
marker for infection. Measurement of CD markers is labour intensive and 
complex. CD64 is a high affinity Fcγ membrane receptor, which binds 
monomeric as well as aggregated IgG. During the early stage of 
granulopoiesis CD64 is expressed. Mature granulocytes do not express 
this receptor[66]. While activated mature granulocytes show elevated 
levels of this membrane protein[67, 68]. 
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3.3 Other sepsis parameters 
Other parameters could contribute to the diagnosis of sepsis. For 
example interleukin-6 is associated with severity and outcome of 
meningococcal septicaemia[69]. Early medical complications may be 
predicted by interleukin-8 when measured at fever onset in patients with 
gram-negative bacteraemia[59]. However, the potential usefulness of 
cytokine measurements in combination with prognostic scores to identify 
patients who may benefit from treatment with anti-inflammatory or 
antithrombotic therapies should be further evaluated[60]. 
Another potential marker might be procalcitonin. Procalcitonin indicates 
not only a probable bacterial infection, but also progression of infection 
into sepsis or septic shock. Despite these findings there are no clinical 
studies available checking the outcome[61, 70]. 
The probable value and usefulness of the above mentioned parameters 
need to be evaluated. 
This object is beyond the scope of this thesis. 
 
 
4 The aim of this thesis 
The aim of this thesis is to investigate the efficacy of microscopic and 
automated blood cell differentiation. Furthermore, to evaluate a new 
promising sepsis marker as alternative for band cells. Since better or 
alternative methods are avialable to obtain the same result compared to 
white blood cell morphology[71], some controversial morphology is 
investigated. Moreover, the important question, to maintain the 
microscopic differential, is answered. 
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Abstract 
It is unusual to find micro-organisms in peripheral blood smears, and 
their presence is frequently associated with overwhelming sepsis and 
consequently a poor prognosis. In this report we demonstrate four cases 
with bacteria in blood smears. Two of them resulted in a fatal outcome, 
but the other two were caused by a contamination either via the central 
venous catheter or in vitro, both without dramatic outcome. The finding of 
bacteria in blood smears has to be interpreted carefully and thorough 
examination of peripheral blood smears may be of great importance in 
the early diagnosis of bacteremia. However, in vitro contamination must 
be excluded. 
 
 
Introduction 
Generally the presence of bacteria in blood is demonstrated by 
conventional blood cultures. Buffy coat smears have proved to be a fast 
method for detecting intracellular bacteria in blood[1-5]. Sometimes 
bacteria are seen in routinely obtained blood smears and become 
sufficiently numerous to be identified in the terminal phase of an 
overwhelming sepsis[6-8]. 
In the specific case of Capnocytophaga canimorsus septicaemia, 
bacteria are present in large numbers in the circulation in the early stage 
of the sepsis, and can therefore be seen in peripheral blood smears[9, 10]. 
Immediate suspicion of the infection may lead to a prompt and adequate 
treatment[11]. The result of the blood culture for Capnocytophaga 
canimorsus, on the other hand, is only available after several days[10, 12]. 
The finding of intracellular bacteria in routine blood smears prepared 
from a blood sample taken from a central venous catheter (CVC) most 
likely indicates catheter related infection[6, 13, 14]. It is then important to 
remove the CVC because bloodstream infection is associated with a 
significant degree of morbidity: case mortality of catheter-related 
bloodstream infection is 10%-20%[15]. 
Finally, blood samples obtained by finger or heel prick may contain 
bacteria or fungi as a consequence of in vitro contamination. In these 
situations bacteria will only be present extracellularly, although, if a long 
period has elapsed from the time of the puncture to the moment of 
preparing the blood smear, phagocytosis by neutrophils may lead to the 
bacteria being intracellular. 
Thorough investigation of the smears may result in the identification of a 
severe sepsis, a CVC related infection or an in vitro contamination. In 
this report we describe that importance of the microscopic detection of 
intra- and extracellular bacteria in blood smears. Four cases are 
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presented of blood smears of patients with severe sepsis with infected 
catheters or with in vitro contamination. 
 
 
Case 1 
A six-month-old baby was admitted to the Emergency Department with 
high fever and suspicion of septic shock. There were no clinical signs of 
meningitis. Respiratory insufficiency was present and the patient was 
intubated, and a CVC was inserted. The patient was transported to the 
paediatric intensive care unit, where therapy with ceftriaxon and 
dexamethason was started. Subsequently inotropics were given. The 
patient developed a bradycardia followed by cardiopulmonary 
resuscitation,  and died the same day. 
The routine laboratory tests showed no remarkable abnormalities with 
the exception of a blood ammonia concentration of 279 µmol/L 
(reference value for our laboratory: < 60 µmol/L), and some abnormal 
coagulation parameters: thromboplastin 100 sec, activated partial 
thrombo plastin time (APTT) 300 sec and fibrinogen 0.110 g/L (reference 
values for our laboratory: 14-17 sec, 20-38 sec and 1.6 – 3.2 g/L 
respectively). The haemoglobin concentration decreased from 5.6 
mmol/L to 2.2 mmol/L and the platelet count decreased during the same 
period from 47 x 109/L to < 10 x 109/L. Blood smears were stained 
according to the May-Grünwald Giemsa method. No neutrophils were 
seen in the blood smears; however, on autopsy it was found that the 
lungs were massively infiltrated with neutrophils. Post mortem samples 
of the various tissues were cultured; no bacteria were found. In the 
routinely blood smears diplococcus-like bacteria were seen which were 
almost always adhered extracellularly to the erythrocytes (figure 1). 
 
 
Case 2 
A previously healthy, 46-year-old man was referred to the hospital 
because of hypotension and abdominal pain. Medical history revealed a 
splenectomy due to trauma 19 years before. At physical examination 
there was dyspnoe, low blood pressure and high fever. 
The abdomen was not distended and showed a left upper quadrant 
incision; on the patient’s left hand there were several small, 3-4 mm 
deep, defects and one lesion of 2 cm with a black non-infected rim due to 
a dog bite, three days before. The white blood cell count was 3.8 x 109/L, 
platelet count was 68 x 109/L, APTT 69 sec, prothrombin time (PT) 1.9 
INR and the C-reactive protein (CRP) was 150 mg/L (reference value for 
our laboratory: <10 mg/L). Other routine laboratory tests were normal. 
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fig 1 
Blood smear of patient 1 with bacteria which are adhered at erythrocytes (900x) 
 
 
fig 2 
Blood smear of patient 2 with intracellular presence of Capnocytophaga Canimorsus 
(900x) 
 
The blood smears were stained according to the May-Grünwald Giemsa 
method. The differentiation of the leukocytes seemed to be normal. 
However, in the neutrophils some rod shaped inclusions were seen 
(figure 2). Three days later blood cultures showed that the blood was 
infected with Capnocytophaga canimorsus, and the patient received 
amoxicillin-clavulanic acid. Treatment with high doses of inotropics, 
artificial respiration, transfusions and hemodialysis was necessary. 
Despite prolonged and adapted antibiotic therapy, the patient developed 
pancreatic necrosis, pulmonary infection (Pseudomonas) and necrosis of 
the left forearm. The patient died on day 21 due to multi-organ failure. 
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Case 3 
A three-year-old girl was admitted to the hospital because of 
pneumatosis intestinalis (PI). One year before she had been diagnosed 
with neuroblastoma stage IV. At the present admission she had 
abdominal pain and bloody diarrhoea. Physical examination showed a 
cheerful girl who did not seem to be ill. The exit site of her CVC was a 
little inflamed. Abdominal examination did not reveal signs of peritonitis. 
Laboratory investigations showed thrombocytopenia with a platelet count 
of 53 x 109/L without neutropenia; the CRP was < 10 mg/L. X-ray of the 
abdomen showed PI of the colon ascendens, flexura hepatica, and 
mesocolon. Furthermore, little free air was seen beneath the diaphragm. 
Because of the pneumatosis, intravenous antibiotics were started 
prophylactically (ceftazidime, metronidazol). After four days the patient 
developed  fever and her clinical condition worsened. A blood culture 
sample, drawn from the CVC, yielded a Staphylococcus epidermis, and a 
second culture of a sample taken from the CVC two days later,  
Staphylococcus aureus. Nine days after admission the CVC was 
removed, and the child recovered. 
From the fourth day until the ninth day of admission, blood smears drawn 
from the CVC showed intracellular and extracellular bacteria (figure 3). A 
peripheral blood smear taken by finger puncture on the sixth day was 
negative. 
 
fig 3 
Blood smear of patient 3 with intracellular cocci in pairs  (900x) 
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Case 4 
An eight-year-old girl had been treated for acute lymphoblastic 
leukaemia. The patient stayed in remission and was seen for routine 
check-up. In the blood smear bacteria, mainly extracellular, were found 
(figure 4), whereas the blood cell count appeared to be normal. 
 
fig 4 
Blood smear of patient 4 with extracellular bundle of cocci (900x) 
 
The patient had no fever nor other indications that she was developing a 
sepsis. A second investigation of the blood smear showed both 
extracellular bacteria and some undefined coloured pieces filled with 
bacteria (figure 5). No abnormalities were seen at the next visit. 
 
fig 5 
Blood smear of patient 4 with undefined coloured piece filled with similar bacteria as 
in Fig 4 (600x) 
 
 
Discussion  
Although bacteria could not be cultured in case 1, the combination of the 
clinical features and the appearance of the blood smears, makes it likely 
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that the patient died due to an infection with Streptococcus pneumoniae. 
It is known that Streptococcus pneumoniae can bind on epithelial cells 
and a mutant has been identified which can attach to all cell types[16, 17]. 
The morphological characteristics of the bacteria, which adhered to 
erythrocytes, are similar to those of Streptococcus pneumoniae. 
The risks of overwhelming sepsis in asplenic patients has been 
recognised over the past decades[7, 18]. Several authors reported an 
infection with Capnocytophaga canimorsus, especially in patients who 
had undergone splenectomy[9-12, 18, 19]. The finding of these rod-shaped 
bacteria in case 2 was the first indication for the infection with this 
bacteria, and was indicative for a bad prognosis. In these patients 
immediate treatment should be desirable. 
Intracellular or extracellular bacteria are frequently found in blood smears 
from patients with central venous catheters (CVC)[6, 13-15, 20]. In most 
cases the patient has an underlying neoplasm and is under treatment 
with immunosuppressive medication. In case 3 blood puncture was 
repeated after seeing bacteria in the blood smears. Again bacteria were 
found. Morphologically these bacteria resembled Staphylococcus. Cocci 
were seen both intracellularly in neutrophils and extracellularly, most 
frequently in pairs. Blood smears obtained by finger puncture did not 
contain bacteria. Blood drawn from the CVC was cultured for bacteria, 
and Staphylococcus epidermis was found. Once the catheter was 
removed no bacteria were seen in subsequent blood smears drawn by 
vene puncture. When bacteria are seen in blood smears drawn by CVC, 
we recommend that a finger puncture should be done to distinguish 
catheter-related sepsis. 
Finally, we described a case with bacteria in a blood smear of a patient 
without any signs or symptoms of infection. Both intracellular and 
extracellular bacteria were present, mostly in small bundles. In addition, 
some undefined coloured pieces were seen in the blood smear filled with 
similar bacteria. This led us to the conclusion in vitro contamination. 
The presence of bacteria in peripheral blood smears may point to 
bacteremia[2,10]. For this reason it is important to report the presence of 
bacteria. However, spurious bacterial findings in blood may be due to 
contamination of the anticoagulant, glassware and so on. For further 
identification a Gram stain can be used. When intracellular bacteria are 
detected, an in vivo infection should be suspected as long as the blood 
smear is prepared using a fresh blood sample. To distinguish bacteremia 
and in vitro  contamination a new blood sample should be obtained. The 
presence of bacteria in blood smears drawn by CVC in combination with 
the absence of bacteria in blood drawn by finger puncture is likely to 
indicate catheter-related sepsis, which may necessitate removal of the 
catheter. 
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Abstract 
This study evaluated inter- and intra-observer variability of band cell and 
atypical lymphocyte differentials and the influence of instrument flagging 
information on resulting microscopic differentials. Five stained slides with 
a range of band cell counts and five with variable numbers of atypical 
lymphocytes were sent for morphological review by 30 technicians. No 
supplementary full blood cell count information was provided. Two 
months later, the same slides were sent together with their 
corresponding analyser reports comprising the full blood cell count, 
automated differentials and flags to the same technicians. The first and 
second appraisals of band cells and variant lymphocytes both showed 
poor levels of inter-observer consistency. Observed values for all slides 
were very wide and suggested a high inherent predisposition to 
erroneous reporting practices. Analysis of category trends showed that 
analyser left shift or IG flags had no influence on observer band cell 
assessments as downward versus upward category revisions were 
evenly balanced. The findings for atypical lymphocytes were, however, 
somewhat different. Two slides with no flags both showed balanced 
category revisions whereas two of the three slides with atypical 
lymphocyte flags showed clear evidence of upward category revision. 
The third slide with an atypical lymphocyte flag did not show any overall 
category trend but six of the seven observers who in the first examination 
recorded atypical lymphocyte estimates of <30% revised their estimates 
upwards when the slides were examined the second time. These results 
suggest that morphologist access to an analyser report and flagging 
information is unlikely to affect the ‘randomness’ of band cell 
determinations but it may induce observer bias in variant lymphocyte 
estimates. 
 
 
Introduction 
The leukocyte differential count is an important component of the routine 
full blood count[1]. A conventional microscopic differential, which is 
typically obtained by visual classification of 100 leucocytes as 
percentages of the five primary cell populations, is however labour-
intensive and has poor confidence limits related to the inherent influence 
of Poisson statistics[2]. In addition, morphological differentials often 
consider qualitative morphological features such as atypical granularity, 
nuclear shape and cytoplasmic colouring and further attempts to quantify 
atypical elements such as band cells (non-segmented neutrophils) and 
‘variant’ lymphocytes[3, 4]. While this additional information may have 
some weight in clinical decision-making processes, there are a number 
of important limitations to this particular aspect of morphological 
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appraisal that need to be considered. For example, although the 
descriptive definition of a band cell is well documented[5-7], the ability of 
individuals to consistently interpret and apply these descriptive 
guidelines is actually quite poor[8]. This problem is even more relevant to 
‘variant’ lymphocytes where there are no standardised definitions and it 
is left to the morphologist to subjectively decide whether any given cell is 
normal or atypical. 
The introduction of cell counters able to generate automated five-part 
differentials (as both relative and absolute counts) resolved many of the 
statistical limitations of the microscopic differential[9-12]. Moreover, the 
general reliability of automated leukocyte differentials has significantly 
reduced conventional morphological reviews. Nevertheless, there 
remains a requirement for morphologists to assess and quantify 
abnormal cell components in certain situations. As one of the facilitating 
‘triggers’ for formal film examination, laboratories commonly utilise 
analyser ‘flags’ or alerts for the suspected presence of abnormal 
leucocytes. However, the possibility that these may be relatively 
inefficient is not well understood, a point that is illustrated by a recent 
report[13] that noted false positive flagging of almost 10% of 
haematologically normal samples as well as a failure to flag 14% of 
abnormal samples. The limitations of some analyser flags may thus lead 
to further inconsistencies in any subsequent morphological classification 
of abnormal cell types. In this context, especially where morphological 
distinctions are marginal, it is feasible that individual morphologists could 
be unduly influenced or biased by analyser flags for abnormal cells when 
morphological review is undertaken. In examining this hypothesis, this 
study evaluated the inter- and intra-observer variability of band cell and 
atypical lymphocyte differentials, and further assessed the influence of 
instrument flagging information on the resulting microscopic differential.  
 
 
Materials and methods 
Samples Studied: 
In this study, five patient samples (A1 to A5) with a range of band cell 
counts and five samples with variable numbers of atypical lymphocytes 
(B1 to B5) were selected by the Nijmegen coordinating laboratory. As 
initial reference, two experienced technicians each differentiated 200 
cells (table 1). For band cells, the morphological criteria of the 
Netherlands Society for Laboratory Haematology were used[7] which 
defines band cells as neutrophils with a nuclear constriction width of one 
half to one third of the maximum nuclear width. For atypical lymphocytes,  
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table 1 Abnormal cell characteristics and influence of flagging information on 
morphological assessmentsa. 
 
Category changedA: 
Neutrophil 
precursors 
 
Selection Differentialb
Supplementary 
Flagging Information 
for Second 
Examinationc
Downwards Unchanged Upwards 
A1 
 
3% band cells Left shift + 
IG + 
0 30 0 
A2 
 
3% band cells Left shift + 4 23 0 
A3 
 
15% band cells IG + 12 9 9 
A4 
 
25% band cells 
3% immature granulocytes 
Left shift + 
 
8 15 7 
A5 
 
20% band cells IG + 8 12 10 
 Category 
change  
 B: 
Atypical 
Lymphocytes 
 
Selection Differentialb
Supplementary 
Flagging Information 
for Second 
Examinationc
Downwards Unchanged Upwards 
B1 
 
90% lymphocytes 
<10% atypical lymphocytes 
Atyps ++ 
LUC 6% 
5 10 15 
B2 
 
45% lymphocytes 
<10% atypical lymphocytes 
No flags 
LUC <5% 
9 11 10 
B3 
 
75% lymphocytes 
30% atypical lymphocytes 
Atyps ++ 
LUC 9% 
5 15 10 
B4 
 
65% lymphocytes 
15% atypical lymphocytes 
No flags 
LUC 8% 
9 12 9 
B5 
 
95% lymphocytes 
75% atypical lymphocytes 
Atyps ++ 
LUC 28% 
9 12 9 
 
a Five coded slides (A1 to A5) with variable degrees of abnormality with granulocyte 
precursors, and five slides associated with atypical lymphoid cells (B1 to B5) were 
examined on two separate occasions by 30 haematology technicians. On the second 
occasion, the slides were accompanied by a full analyser report (Bayer Advia 120) 
containing WBC count, differential and flagging information.  
b Selection differential obtained by two independent observers each recording 200 
leucocytes. The percentage lymphocytes refers to the percentage of the complete 
differential and the percentage atypical lymphocytes corresponds to the percentage 
of the lymphocyte fraction with atypical morphology.  
c Supplementary information provided in the form of a full analyser report. Flagging 
information shown here corresponds to those of most relevance. IG corresponds to 
immature granulocytes, Atyps to atypical lymphocytes, and LUC to large unstained 
cells. 
d Category change indicates the number of downward, unchanged or upward 
category revisions (of 30 in total) when the second examination was compared with 
the first (tables 2 and 3). The four band cell categories used in this study were (i) 0-
5%, (ii) 6-10%, (iii) 11-20% and (iv) >20%. The four variant lymphocyte categories 
used in this study were (i) 0-10%, (ii) 11-30%, (iii) 31-60% and (iv) >60%.  
 
broader definitions of irregular cytoplasmic or nuclear shape were 
applied. The normal reference range of band cells in adult blood is 
generally regarded as <5% while the normal frequency of atypical 
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lymphocytes (expressed as a proportion of the lymphocyte fraction) is 
considered as <10%. 
For each sample, a set of May-Grünwald Giemsa stained slides was 
prepared and sent for morphological review by 30 technicians based in 
three different laboratories. No supplementary full blood cell count (FBC) 
information was provided and the technicians were asked to 
independently perform a 100-cell leukocyte differential including 
proportionate determinations of band cells, immature granulocytes, 
atypical lymphocytes and blast cells. This initial assessment (First 
Examination) was followed two months later by circulation of the same 
slide sets (with different coding) accompanied by full automated analyser 
reports (Bayer Advia 120, Bayer, Tarrytown, USA) comprising the FBC, 
automated differentials and flags for atypical lymphocytes (Atyps), blasts, 
left shift and/or immature granulocytes (IG). This particular report format 
was selected as all 30 technicians involved in the morphological study 
had direct experience of working with this analyser. 
Statistical Analysis: 
Analysis of observer variability of band cell and atypical lymphocyte 
differential estimates was determined separately for both the First and 
Second Examinations. Paired comparisons further provided an 
assessment of intra-observer consistency and the influence of 
supplementary flagging information on possible observer bias. Inter-
observer reproducibility was established by assessing variability (median 
and observed ranges) for each data set. Paired comparisons (First 
versus Second Examination) for each slide were then evaluated with the 
non-parametric Wilcoxon Signed Ranks Test and the Weighted Kappa 
test for category agreement. 
 
 
Results 
Summarised results for the series of five samples (A1 to A5) used for 
evaluating band cell variability are shown in table 2. The range of 
observed values for both the First and Second Examination was wide for 
all samples with the exception of slide A1 where the band cell count was 
low. Interestingly, a second slide in this series (A2) with low band cells 
showed much wider inter-observer variability. Of additional relevance 
was the finding that for the other three samples where most observers 
correctly recorded increased band cells, there were some morphologists 
whose assessments suggested normality. Paired comparisons (Wilcoxon 
Signed Ranks Test) between the First and Second Examinations 
however indicated no significant difference between the median band 
cell values (table 2). Compared to the inconsistency of band cell 
estimates, it is pertinent to note that the small percentage of immature 
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granulocytes (myelocytes and metamyelocytes) in slide A4 was recorded 
by virtually all (27/30) observers (data not shown).  Moreover, the intra-
observer paired comparisons of these immature granulocytes were all 
within statistically predicted 95% confidence limits[14]. 
 
 
table 2 Analysis of paired band cell and variant lymphocyte evaluation data. 
Slide  First examination Second examination Difference1
A1 
 
 
Mean (SD) 
Observed range 
1.0%(1.2) 
0 – 5% 
1.2%(1.0) 
0 – 4% 
ns 
A2 
 
 
Mean (SD) 
Observed range 
2.8%(3.2) 
0 – 15% 
2.4%(2.2) 
0 – 8% 
ns 
A3 
 
 
Mean (SD) 
Observed range 
9.0%(5.5) 
2 – 27% 
8.3%(5.7) 
2 – 20% 
ns 
A4 
 
 
Mean (SD) 
Observed range 
19.0%(7.9) 
5 – 35% 
19.2%(7.4) 
7 – 40% 
ns 
A5 
 
 
Mean (SD) 
Observed range 
11.0%(6.6) 
1-24% 
13.4%(7.5) 
4-33% 
ns 
 
 
    
Slide     
B1 
 
 
Mean (SD) 
Observed range 
15.2%(17.0) 
0 – 50% 
33.2%(15.2) 
5 – 100% 
p=0.03 
B2 
 
 
Mean (SD) 
Observed range 
34.3%(28.4) 
0 – 100% 
38.5%(29.4) 
0 – 95% 
ns 
B3 
 
 
Mean (SD) 
Observed range 
15.9%(16.6) 
0 – 60% 
23.3%(23.5) 
0 – 100% 
ns 
B4 
 
 
Mean (SD) 
Observed range 
28.5%(28.5) 
0 – 100% 
29.8%(32.0) 
0 – 100% 
ns 
B5 
 
 
Mean (SD) 
Observed range 
58.0%(28.6) 
5 – 100% 
61.7%(25.0) 
0 – 100% 
ns 
1 Wilcoxon Signed Ranks Test (2-tailed p) for differences between medians of related 
sample sets, ns indicates no significant difference (p>0.05). 
 
 
Similar assessments of atypical lymphocytes revealed an extremely poor 
degree of observer consistency, although comparisons of First and 
Second Examinations did not indicate, with the exception of slide B1, any 
significant differences in the median values distributions. However, the 
interpretative relevance of this is minimal because of their wide observed 
ranges, and the limitations of paired data set comparisons when intra-
observer trends (i.e. Second versus First Examination) are random. 
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To better understand and quantify this, the individual observer results 
were categorised into four groups according to reported severity of the 
abnormality. For band cells, these categories were 0-5%, 6-10%,  
 
table 3 Intra-observer agreement for first and second band cell examinations. 
Slide A1 First reading  
Second reading 0-5% 6-10% 11-20% >20% Total
0-5% 30 0 0 0 30 
6-10% 0 0 0 0 0 
11-20% 0 0 0 0 0 
>20% 0 0 0 0 0 
Total 30 0 0 0 30 
Weighted Kappa test for category agreement: 1.00 
 
Slide A2 First reading  
Second reading 0-5% 6-10% 11-20% >20% Total
0-5% 23 3 1 0 27 
6-10% 3 0 0 0 3 
11-20% 0 0 0 0 0 
>20% 0 0 0 0 0 
Total 26 3 1 0 30 
Weighted Kappa test for category agreement:  <0.10 
 
Slide A3 First reading  
Second reading 0-5% 6-10% 11-20% >20% Total
0-5% 4 5 2 0 11 
6-10% 3 2 4 0 9 
11-20% 3 3 3 1 10 
>20% 0 0 0 0 0 
Total 10 10 9 1 30 
Weighted Kappa test for category agreement:  0.16 
 
Slide A4 First reading  
Second reading 0-5% 6-10% 11-20% >20% Total
0-5% 0 0 0 0 0 
6-10% 0 2 2 1 5 
11-20% 1 2 5 5 13 
>20% 0 1 3 8 12 
Total 1 5 10 14 30 
Weighted Kappa test for category agreement:  0.36 
 
Slide A5 First reading  
Second reading 0-5% 6-10% 11-20% >20% Total
0-5% 3 1 1 0 5 
6-10% 2 3 3 0 8 
11-20% 2 2 5 3 12 
>20% 1 1 2 1 5 
Total 8 7 11 4 30 
Weighted Kappa test for category agreement:  0.27 
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11-20% and >20%, and for atypical lymphocytes the categories were 0-
10%, 11-30%, 31-60% and >60%.  When the paired categorised data 
were cross-tabulated and weighted kappa values for agreement 
determined a number of important observations became apparent. Only 
one of the five slides (A1) in the band cell study showed an acceptable 
degree (kappa>0.8) of intra-observer reproducibility (table 3). 
For the other four slides (A2 to A5), an inability for many individual 
observers to reproducibly observe and quantify band cell components 
was clearly apparent. Similar analyses (table 4) of the five slides in the 
atypical lymphocyte study showed that the majority of observers were 
unable to reproducibly assess this abnormality. Category agreement was 
very poor and a significant number of paired results showed quantitative 
revision of two categories or more. 
Analysis of category trends (table 1) for the two slide series showed that 
the presence or absence of left shift or IG flags had no influence on 
observer band cell assessments as the downward versus upward 
category revisions were evenly balanced (i.e. reflecting observer 
inconsistency rather than bias). The findings for atypical lymphocytes 
were, however, somewhat different. The two slides with no flags (B2 and 
B4) both showed balanced category revisions whereas two (B1 and B3) 
of the three slides with atypical lymphocyte flags showed clear evidence 
of upward category revision (i.e. the reporting of higher numbers). The 
remaining slide (B5) with an atypical lymphocyte flag did not show any 
apparent category trend (table 1). However, closer examination of the 
results for this particular slide (table 4) revealed that six of the seven 
observers who in the first examination recorded atypical lymphocyte 
estimates of <30% revised their estimates upwards when the slides were 
examined the second time. Virtually all of the downward revisions for this 
sample were from >60% to 31-60% and thus of lesser significance. 
 
 
Discussion 
There are many literature reports that detail the limitations of 
morphological analysis and consistency of leukocyte population 
estimates, particularly when the cell types concerned are defined by 
criteria that are relatively subjective. However, as far as we are aware 
this is the first study which has specifically evaluated the potential 
influence of observer bias (subconscious or otherwise) introduced by 
awareness of instrument flagging information. The design of this study, 
whereby the Second Examination of the band cell and atypical 
lymphocyte slide sets was accompanied by an analyser report with 
leukocyte differential and flagging information, was designed to provide 
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table 4 Intra-observer agreement for first and variant lymphocyte examination. 
Slide B1 First reading  
Second reading 0-10% 11-30% 31-60% >60% Total
0-10% 6 0 0 0 6 
11-30% 5 3 5 0 13 
31-60% 4 2 1 0 7 
>60% 2 1 1 0 4 
Total 17 6 7 0 30 
Weighted Kappa test for category agreement:  0.19 
 
Slide B2 First reading  
Second reading 0-10% 11-30% 31-60% >60% Total
0-10% 3 3 0 2 8 
11-30% 2 3 2 1 8 
31-60% 1 3 3 1 8 
>60% 3 1 0 2 6 
Total 9 10 5 6 30 
Weighted Kappa test for category agreement:  0.12 
 
Slide B3 First reading  
Second reading 0-10% 11-30% 31-60% >60% Total
0-10% 10 2 1 0 13 
11-30% 5 3 2 0 10 
31-60% 1 2 2 0 5 
>60% 1 1 0 0 2 
Total 17 8 5 0 30 
Weighted Kappa test for category agreement:  0.34 
 
Slide B4 First reading  
Second reading 0-10% 11-30% 31-60% >60% Total
0-10% 8 3 2 0 13 
11-30% 3 1 3 1 8 
31-60% 1 1 1 0 3 
>60% 0 2 2 2 6 
Total 12 7 8 3 30 
Weighted Kappa test for category agreement:  0.33 
 
Slide B5 First reading  
Second reading 0-10% 11-30% 31-60% >60% Total
0-10% 0 0 0 1 1 
11-30% 0 1 1 1 3 
31-60% 3 1 2 6 12 
>60% 1 1 3 9 14 
Total 4 3 6 17 30 
Weighted Kappa test for category agreement:  0.07 
 
some insights into whether or not such information could subconsciously 
bias morphologist’s individual assessments. If the appearance of a 
specific flag led to a biased increase in the recorded number of band 
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cells or atypical lymphocytes, then this would be reflected by an upward 
trend in categorised results. Conversely, the absence of the respective 
flags would lead to a downward trend if morphologists were biased. 
Imprecision of conventional microscope differentials results from the 
combined effects of inherent (Poisson) statistical limitations and observer 
inconsistencies. Observer subjectivity is particularly relevant to the 
delineation of abnormal populations such as band cells and variant 
lymphocytes where there remains considerable variability despite 
attempts to provide workable morphological definitions. 
Recommendations for standardising morphological criteria for band cells 
have largely failed[4, 15, 16], and the situation with variant lymphocytes is 
even less satisfactory because the diversity of morphological changes in 
reactive and malignant conditions fundamentally prevents the use of 
empirical morphological guidelines. Thus, while it is true that observers 
will agree and consistently recognise obvious morphological 
disturbances such as cytoplasmic basophilia, nuclear eccentricity or 
nucleolation, there is much less agreement when these changes are 
more subtle (e.g., cytoplasmic or nuclear pleomorphism). 
Band cells and variant lymphocytes are cell types that are often viewed 
as indicators of possible bacterial or viral infection when their frequency 
or number in blood samples exceeds the generally accepted upper 
normal limits of 5% or 10% respectively. It is apparent however that this 
theoretical clinical potential would be equally compromised by either a 
failure in recording the presence of atypical cells or, alternatively, for a 
morphological reviewer to suggest the presence of atypical cells when in 
fact they do not exist. 
This study evaluated inter- and intra-observer variability of band cell and 
variant lymphocyte differential estimates by using a somewhat novel 
experimental approach. The initial part of the study essentially confirmed 
the perceptions of most morphologists that there is poor concordance 
between individual observers when designating these leukocyte 
populations. As mentioned earlier, these inconsistencies are to some 
extent a consequence of the Poisson error associated with a 100 cell 
differential. However, our finding that the inter-observer agreement level 
for the minor population of immature granulocytes (metamyelocytes and 
myelocytes) in slide A4 was very good strongly suggests that it is 
specifically the morphological subjectivity of less well-defined leukocyte 
fractions that is the main contributor to variability. 
It can of course be reasonably argued that when the morphological 
definition(s) of any specified leukocyte population is inadequate or 
difficult to apply, then the resulting morphological subjectivity is likely to 
be high. Moreover, when subjectivity is high it is quite conceivable that 
non-morphological factors could have a significant influence on observer 
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decisions with respect to leukocyte differential categorisation. This 
essentially refers to the potential impact of conscious or 
subconconscious observer bias on final outcomes that may result from 
(for example) prior awareness of clinical diagnosis, patient 
symptomology or abnormal flagging alerts provided by haematology 
analysers. Consequently, it is necessary to consider these aspects when 
interpreting our findings of poor intra-observer reproducibility for 
individual morphologists who reviewed the same slides on two separate 
occasions. If this intra-observer variation was due to Poisson statistics 
and random morphological inconsistencies, then one would expect to 
find no significant trend change between the first and second 
morphological appraisals. If on the other hand, a distinct trend change 
was observed then this would strongly suggest that the analyser report 
and flagging information accompanying the second morphological 
assessment influenced or biased the observer. 
Our paired analysis of band cell estimates suggested that supplementary 
flagging information had little or no influence on observer bias, nor did it 
positively affect the consistency of reported results. In contrast, it was 
clear that when analyser flags indicated the presence of atypical or 
variant lymphocytes that a significant degree of observer bias could be 
introduced. 
In conclusion, these results suggest a morphological dilemma. If 
morphological reviews of band cells and variant lymphocytes are 
undertaken with no prior awareness of haematological or clinical 
information, then the final report and interpretation may reflect the 
‘idiosyncrasies’ of the observer as well as statistical limitations. On the 
other hand, if the morphologist has access to an analyser report and 
flagging information, then it will have no effect on the ‘randomness’ of the 
band cell determination but it might induce observer bias in the variant 
lymphocyte estimate. Either way, the resulting reported information could 
be clinically misleading and thus counter-productive. On the basis of our 
findings, we do not recommend the routine determination and reporting 
of band cell and variant lymphocyte differentials unless unequivocally 
present in increased numbers. Moreover, the limited accuracy and clear 
inconsistency of quantifying these leukocyte fractions suggest that a 
simple appended comment of ‘normal’ or ‘increased’ may be preferable 
and less ambiguous. 
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Abstract 
Objectives 
The differentiation of white blood cells is a worldwide-accepted method 
to obtain medical information. The conventional microscopic differential 
however, is a laborious and expensive test with a low statistical value. 
Especially for band cell identification there is a wide range of variance. In 
this report we describe the intervariability of band cell enumeration. 
Methods 
From a septic patient, an EDTA anticoagulated blood sample was 
obtained and a smear was made and stained (May-Grünwald Giemsa). A 
PowerPoint presentation was made twice of 100 random cells and sent 
to 157 different hospital laboratories in The Netherlands for a leukocyte 
differential. In the first survey, neutrophils were differentiated in 
segmented and band neutrophils whereas in the second survey no 
discrimination was made between segmented and band neutrophils. 
Results 
The first survey was responded by 68% of the laboratories (756 
individuals) and the second survey by 73% of the laboratories (637 
individuals). The laboratory mean values of the segmented neutrophils 
were 42.9% (sd: 7.8, range 22-64%) and 69.9% (sd: 1.4, range 62-72%) 
for the first and second survey, respectively. For the individual 
technicians the values of the segmented neutrophils were 43.9% (sd: 
11.2, range 15-72%) and 70.0% (sd: 2.0, range 59-77%) for the first and 
second survey, respectively. 
Conclusions 
Because of the enormous variation of band cell counting we recommend 
to cease quantitative reporting of band cells, especially since the results 
only have a clinical relevance in a limited number of pathological 
circumstances. 
 
 
Introduction 
The differentiation of white blood cells is a worldwide-accepted method 
to obtain information about diagnosis, follow-up and treatment of illness. 
However, the microscopic differentiation is labour intensive and 
inaccurate[1]. Enumeration of band cells has low clinical utility, but 
clinicians still use the number of band cells as a parameter for infection[2]. 
Although the descriptive definition of a band cell is well documented[3-5], 
the ability of individual technicians to consistently apply these descriptive 
guidelines is actually quite poor[2]. Lack of consistent interpretation of the 
band cell identification criteria leads to considerable variation in 
reference ranges[6-8]. 
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Modern haematology analysers are able to generate automated five-part 
differentials (expressed in relative as well as absolute counts) and 
resolve many of the statistical limitations of the microscopic differential[9, 
10]. Technical improvements have lead to expansion of the morphological 
subtypes of cell classes, e.g. immature granulocytes,[11, 12] that can be 
recognised. Moreover, the general reliability of automated leukocyte 
differentials has significantly reduced conventional microscopic reviews. 
Flagging for morphological abnormalities, however, still has little 
sensitivity[13]. In addition, flagging for abnormalities may lead to 
overestimation of the number of abnormalities. Remarkably, this is not 
the case for band cells, probably due to the enormous inter- and 
intravariation in band cell enumeration[14]. Recently, an automated image 
recognition system has been developed and evaluated. This may reduce 
microscopic examination of blood smears[15]. However, traditional 
microscopy will continue to be used in routine haematology in 
combination with automated image recognition systems. Further 
advances in the technology of automated image recognition systems can 
be expected to create new challenges for the blood cell image 
interpretation[16]. 
External quality assurance programs for microscopic leukocyte 
differential counts is needed to improve morphological performance and 
uniform assessment of blood cells. Fixed, unstained blood smears are 
sent to participating laboratories and differentiated by technologists. All 
results are evaluated and reported to the participants. In this report we 
describe the intervariability of band cell enumeration. To exclude sample 
variation we have made two PowerPoint presentations containing both 
100 different leukocytes, which were sent to 157 hospital laboratories. 
For the first survey, neutrophils had to be differentiated in segmented 
and band neutrophils whereas in the second survey no discrimination 
was asked between segmented and band neutrophils. 
The aim of this study is to prove that the intervariability of enumeration of 
band cells is controversial. 
 
 
Materials and methods 
A blood smear was prepared from a septic patient and stained according 
to the method of May-Grünwald Giemsa. From the slide 100 leukocytes 
were randomly selected and micro photographed and each cell was 
presented in a PowerPoint presentation. This presentation was sent to 
157 hospital laboratories in the Netherlands for assessment of each 
leukocyte type. All data were processed in Excel files for further analysis. 
After one year another set of 100 images was derived from the same 
blood smear and processed into a PowerPoint presentation. This 
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presentation was sent to the same laboratories requesting to differentiate 
the leukocytes. However, participants were now asked to count band 
cells as neutrophils. If band cells were present, it was requested to report 
this by means of a plus, independent of the amount of band cells. 
For each cell the accordance was investigated as a percentage of similar 
assessment for each cell. 
For data analysis Anova unpaired t-test with Welch’s correction was 
used. 
 
table 1. The mean values of leukocyte types reported through the laboratories in the 
first and second survey 
Leukocyte type First survey (n=106) Second survey (n=114) 
 Mean 
(%) 
Sd 
(%) 
Range 
(%) 
CV 
(%) 
 Mean 
(%) 
Sd 
(%) 
Range 
(%) 
CV 
(%) 
Monocytes 12.4 2.2 3-15 17  8.4 2.9 0-13 34 
Lymphocytes 6.6 1.5 3-15 23  15.8 1.2 8-19 7 
Segmented 42.9 7.8 22-64 18  69.9 1.4 62-72 2 
Band cells 31.4 7.6 11-52 24  - - - - 
Metamyelocytes 4.4 1.6 0-10 36  2.9 1.4 0-9 48 
Myelocytes 0.8 0.9 0-0 100  1.8 2.1 0-12 100 
Eosinophils 0.0 0.1 0-0 -  0.0 0.1 0-0 - 
Basophils 1.0 0.1 0-2 10  0.0 0.0 0-0 - 
otherwise 0.5 0.6 0-3 100  1.2 1.8 0-11 100 
 
Results 
Of 157 laboratories, 106 (68%) responded to the first survey and 114 
(73%) to the second test. For the first survey 756 individual results were 
received and 637 from the second survey. 104 Laboratories responded 
to both the first and the second survey. 
Laboratory means. 
The laboratory mean of segmented neutrophils count for the first survey 
was 42.9% with a standard deviation (sd.) of 7.8%, a range of 22 - 64% 
and a coefficient of variation (CV) of 18%. The laboratory mean 
neutrophil count (=segmented neutrophils and band cells) for the second 
survey was 69.9% with a sd. of 1.4%, a range of 62 - 72% and a CV of 
2%. See table 1 for the results of the other cell categories. Results from 
both surveys were compared for every category using the unpaired t-test 
with Welch’s correction for each cell type. This resulted in a statistical 
significant difference (p<0.0001) for neutrophils. 
Individual means. 
The individual technician mean segmented neutrophil count, for the first 
survey was 43.9% with a sd. of 11.2%, a range of 15 - 72% and a CV of 
25%. The individual technician mean neutrophil count for the second 
survey was 70.0% with a sd. of 2.0%, a range of 59 - 77% and a CV of 
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3%. See table 2 for the results of the other cell categories. Results from 
both surveys were compared for every category and resulted in a 
significant difference (p<0.0001) for neutrophils. 
Individual observer data for each cell. 
First survey. As each observer was shown the same set of cells, the 
agreement between participants in this study in categorizing each cell 
could be analysed. For the segmented neutrophils >75% accordance 
between participants was achieved for 27 cells. For band cells 14 cells 
showed a better than 75% accordance. For 19 segmented neutrophils 
and 13 band cells accordance was less than 75% (figure 1). 
Second survey. In the second survey, participants showed more than 
75% accordance for 69 out of 70 neutrophils. Only one neutrophil cell 
reached less than 75% accordance in categorizing. The presence of 
band cells was reported in 632 out of 637 observations (99.2%). 
Additionally, monocytes and (meta)myelocytes showed standard 
deviations of 0.9-2.9% (table 1) for the laboratory values and 1.4 - 3.9% 
(table 2) for the individual values. 
 
 
fig 1 
Overview of the neutrophils from the first survey. 1a: 27 Cells with an accordance of 
>75% for segmented neutrophils. 1b: 14 Cells with an accordance of >75% for band 
neutrophils. 1c: 32 Cells with an accordance <75% for segmented neutrophils or 
band neutrophils. 
 
 
Discussion 
The leukocyte differential count is an important component of the routine 
full blood count [17]. Detection of a granulocytic left shift in microscopic 
differential counts is often used as an indicator for infection or sepsis. 
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table 2 The mean values of leukocyte types reported through by individuals in the 
first and second survey 
Leukocyte type First survey (n=756) Second survey (n=637) 
 Mean 
(%) 
Sd 
(%) 
Range 
(%) 
CV 
(%) 
 Mean 
(%) 
Sd 
(%) 
Range 
(%) 
CV 
(%) 
Monocytes 12.4 3.1 2-19 25  8.4 3.9 0-21 46 
Lymphocytes 6.6 1.8 1-18 27  15.8 1.9 7-23 12 
Segmented 43.9 11.2 15-72 25  70.0 2.0 59-77 3 
Band cells 30.6 11.0 4-64 36  - - - - 
Metamyelocytes 4.2 2.4 0-15 57  3.0 2.6 0-15 87 
Myelocytes 0.8 1.4 0-13 100  1.6 2.5 0-16 100 
Eosinophils 0.0 0.1 0-1 -  0.0 0.2 0-3 - 
Basophils 1.0 0.2 0-3 20  0.0 0.1 0-1 - 
otherwise 0.5 1.1 0-8 100  1.2 2.3 0-15 100 
 
 
Traditionally, a left shift has been defined as an elevated neutrophil band 
count[2, 18]. In the leukocyte index band cells are used to calculate the 
immature to total neutrophil ratio. According to some authors the 
leukocyte index could provide supplement information in sepsis 
diagnosis[19]. However, other authors dispute this statement[20]. Despite 
explicit national and international guidelines, a uniform discrimination 
between band cells and segmented neutrophils has never been 
achieved[21]. In our study we found a wide variation in results, both 
between individuals and laboratories. In previous statistical studies 
Rümke developed a model for differentials[1] showing that a 100-cell 
differentiation is by definition a statistically unreliable sample check. His 
model is based on sample variance: observation of the same cells by 
different observers is mere coincidence. In our investigation all 
technicians observed identical cells and this should therefore reduce 
sample variance. 
Differentiation of neutrophils in segmented and band cells lead to a 
standard deviation of 11.2% for segmented neutrophils and 11.0% for 
band cells in a range of  15-72% and 4-64%, respectively. These results 
differ significantly from those of the other cells, where statistically 
differences between the results of the mean from different observers 
were mainly due to the low number of the cells in the PowerPoint 
presentation.  
This study shows that qualitative reporting of band cells leads to a 
considerable reduction in standard deviation to circa 2% for neutrophils 
in the range of 59-77%. Of all 637 observers, 632 (99,2%) reported the 
presence of band cells. 
The clinical utility of band cells in children older than 3 months of age is 
poor [2]. Nevertheless, enumeration of band cells is still required for the 
Rochester criteria and for the calculation of the immature to total 
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neutrophil ratio. But due to the enormous interobserver variation of band 
cell enumeration, one should reconsider the use of quantifying the 
number of band cells. Results of band cell numbers should at least be 
interpreted with great care. The number of band cells may suggest a left 
shift, which may be a sign for infection[21]. Other neutrophil precursors 
such as metamyelocytes are less controversial and can provide the 
same information. However, the accordance for monocytes and 
(meta)myelocytes was poor. This may be due to the inter variation of the 
staining method. The technicians may be attuned to another colour 
intensity for monocytes and (meta)myelocytes. For this reason especially 
these cells were confused with each other. With the introduction of other 
diagnostic parameters for the detection of sepsis or infection (e.g. CRP, 
procalcitonin, cytokines), the need to differentiate band cells from 
segmented neutrophils will diminish. Anticipating on these new 
developments, we recommend ceasing enumeration of band cells in 
daily clinical practice. 
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Abstract 
It is commonly accepted that classification of abnormal lymphocytes in 
peripheral blood smears contributes to a rapid diagnosis of lymphocyte 
disorders. In this paper we describe the inconsistent morphological 
assessment of subtypes of lymphocytes in a nationwide morphology 
query. A PowerPoint presentation was made of 100 at random micro 
photographed white blood cells. This presentation was sent to 157 
laboratories in The Netherlands resulting in a response of 73% (114 
laboratories; 671 results of individual technicians). Participants were 
asked to subdivide the lymphocytes in normal, atypical lymphocytes, 
plasma cells, prolymphocytes or (lympho)blasts. There were 56 pictures 
of lymphocytes. Of these lymphocytes only seven cells were 
unanimously classified as normal lymphocytes, for 30 cells two different 
subtypes were mentioned, for 11 cells three different subtypes were 
mentioned, for 7 cells four different subtypes were made and in one case 
even all five subtypes were mentioned. One cell was showed twice in the 
PowerPoint presentation and this resulted in an inconsistent 
classification for 210 out of 671 observers (31%). Support of additional 
clinical information may improve the classification of abnormal 
lymphocytes. 
 
 
Introduction 
An examination of a blood smear may be requested by physicians or 
initiated by laboratory staff as diagnostic aid when a lymphoproliferative 
disorders or mononucleosis is suspected[1]. The classification of 
lymphocyte disorders is complex because of the various manifestations 
of these disorders[2,3]. Three major groups can be distinguished: reactive 
lymphocytosis, premalignant neoplastic disorders of lymphocytes and 
neoplastic disorders of lymphocytes[4]. Lymphocyte disorders may be 
accompanied by abnormal lymphocyte morphology. Therefore, it is 
important to recognize and report abnormal lymphocytes, such as 
atypical lymphocytes and lymphoblasts. The ability of individual 
technicians, however, to recognize abnormal lymphocytes consistently is 
quite poor[5]. There are no standardised definitions regarding the 
morphology of the various cells, and interpretation is based on individual 
experience and dependent on the availability of additional clinical 
information. Often, transitional forms between lymphocytes and plasma 
cells are seen in the blood of patients with viral infections. These cells 
are variously known as atypical lymphocytes, lymphocytoid plasma cells 
or plasmacytoid lymphocytes[6]. The so-called atypical lymphocyte is a 
non-neoplastic lymphocyte seen in the peripheral blood, and appears to 
be a non-specific response to stress from a variety of disorders[7]. Small 
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lymphocytes become larger in size and become capable of dividing. 
These atypical lymphocytes vary in morphology and surface markers[8,9].  
Hoagland developed criteria for diagnosis of infectious mononucleosis 
comprising ≥50% of the white blood cell differential with atypical 
lymphocytes accounting for ≥10% of the total WBC count[10]. The 
morphology of lymphoblasts is even more complicated, as morphological 
appearance varies from small cells with scanty cytoplasm and coarse 
chromatin to large cells with an abundance of vacuolated cytoplasm and 
fine chromatin[11]. 
The morphological assessment of the peripheral blood smear remains a 
valued diagnostic tool [1], despite the considerable interobserver variation 
in interpretation. New techniques such as automated recognition 
systems may reduce the microscopic review of blood films in the near 
future[12].  Nevertheless, the relevance of the morphological evaluation of 
abnormal lymphocytes can be questioned, considering the large variation 
in reported results. 
In this paper we demonstrate the general inconsistency in reporting 
whether an abnormal lymphocyte is (non-neoplastic) reactive, neoplastic 
or an arte fact. 
 
 
Material and Methods 
From a blood smear of an orthopaedic patient (female, age 3 years) with 
a lymphocytosis, which was normal for a child with that age, 100 white 
blood cells were randomly selected, micro photographed and processed 
in a PowerPoint presentation. This PowerPoint presentation was sent to 
157 different hospital laboratories in The Netherlands and a leukocyte 
differential was requested. All participants were asked to differentiate the 
lymphocytes in normal lymphocytes, atypical lymphocytes, plasma cells, 
prolymphocytes or (lympho)blasts. Participants did not have any 
information of the patient. 
All results were processed in Excel and for each laboratory and 
individual technician the mean differential was calculated. For each 
lymphocyte subtype the degree of concordance was calculated.  
 
 
Results 
Of the 157 Laboratories 114 responded (73%) with a total of 671 
individual results. The overall mean lymphocyte count (including cell 
subtypes) was 56%. For 7 cells there was a concordance of >90% for 
normal lymphocyte (figure 1a), which means that more than 90% of the 
individual observers called these cells normal lymphocytes. For the other 
49 lymphocytes there was no concordance in subtyping at all. In 
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majority, lymphocytes (29 cells) were classified as normal or atypical 
(figure 1b). One cell (figure 1c) was classified as a normal lymphocyte or 
a plasma cell. Nine cells were classified as normal or atypical or 
prolymphocyte (figure 1d) and two cells as normal or atypical or plasma 
cell (fig. 1e). For seven cells four different subtypes were mentioned 
(figure 1f and g), and one cell was attributed for five different 
assessments (figure 1h). 
One cell (figure 2) was shown twice in the PowerPoint presentation: in 
210 out of 671 the same cell was classified by the same observer as 
another subtype. 
 
fig 1 
Examples of the different lymphocytes. Lymphocytes classified as:  a; lymphocyte 
with >90% accordance,  b; normal or atypical, c; normal or plasma cell, d; normal,  
atypical or prolymphocyte, e; normal, atypical or plasma cell, f; normal, atypical, 
prolymphocyte or plasma cell, g; normal, atypical, prolymphocyte or blast,  h; normal, 
atypical, prolymphocyte, plasma cell or blast. 
 
 
fig 2 
The duplicate lymphocyte 
 
 
Discussion 
Even in the age of molecular analysis and sophisticated laboratory tests, 
the blood smear remains an important diagnostic tool[1]. The recognition 
of abnormal lymphocytes in blood smears can contribute to a rapid 
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diagnosis of various diseases, both reactive and (premalignant) 
neoplastic, and enables rapid therapeutic intervention. Some rare 
diseases may be diagnosed faster by a critical review of the 
lymphocytes, such as I-cell disease[13]. The need for recognition of 
abnormal lymphocytes should not be underestimated. The morphology of 
lymphocytes is complex: Cell size, amount and colour of cytoplasm, as 
well as shape and chromatin structure of the nucleus, must be combined 
to come to a good characterisation of the lymphocyte. Diagnosis of 
infectious mononucleosis may be based on Hoagland’s criteria. 
However, previous studies have questioned the percentage of patients 
with serologic evidence using these criteria[14]. Unfortunately, a uniform 
definition of abnormal lymphocytes is lacking. A confusing terminology is 
used for abnormal lymphocytes, e.g. variant lymphocytes, atypical 
lymphocytes and even combinations of several cells are used, e.g. 
monocytoid lymphocytes and plasmacytoid lymphocytes. In this study we 
demonstrated the variability in classification of abnormal lymphocytes 
and would recommend interpreting and reporting abnormal lymphocytes 
with care. One cell was shown twice in the PowerPoint presentation 
(figure 2), and remarkably 31% of the morphologists was not able to 
reproduce their previous classification. This illustrates the problem of 
uniform and consistent reporting of the subtypes of abnormal 
lymphocytes even more clearly. 
In spite of the fact that highly qualified technologists spend large amount 
of time on manual microscopy, clinicians base their diagnosis and 
treatment often on other information. This is because clinicians have 
access to physical findings, X-rays, cultures etc.[15] We recommend 
providing additional clinical information, which should lead to a better 
interpretation of blood cell morphology. However, additional information 
of the automated haematology analysers could lead to overestimation of 
abnormal lymphocytes[5]. 
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Abstract 
In general, peripheral blood smears are performed to obtain information 
with regard to various morphological features as an aid in the diagnosis 
of infection or malignancy. 
Here, we present a patient with I cell disease (Inclusion-cell disease), a 
fatal lysosomal storage disorder caused by a defect in an enzyme 
responsible for the transfer of mannose-6-phosphate ligands to precursor 
lysosomal enzymes. As a consequence, most lysosomal enzymes are 
transported outside the cell instead of being correctly targeted into the 
lysosomes, resulting in storage of macromolecules in lysosomes. 
I cell disease, with its heterogeneous clinical presentation, can be 
diagnosed by the presence of intracellular vacuole-like inclusions in 
lymphocytes and fibroblasts, high serum lysosomal enzyme activities 
and a defect of N-acetylglucosamine-1-phosphotransferase. 
In this report we describe the morphological aspects of peripheral 
lymphocytes in a blood smear of a patient, the first clue to the final 
diagnosis of I-cell disease. The observed vacuole-like inclusions in 
lymphocytes of this patient were negative for Periodic Acid-Schiff (PAS) 
and Sudan Black B staining, in contrast to earlier reports. 
 
 
Introduction 
I cell disease is a rare autosomal recessive lysosomal storage disorder, 
first described in 1967[1], which manifests at birth and slowly progresses 
in a fatal outcome at approximately 4 years of age[1-3]. The disease, 
although heterogeneous in its clinical presentation, has some 
characteristic features, namely: psychomotor retardation, skeletal 
abnormalities, shortness of stature and a Hurler-like appearance. 
Intracellularly, a generalised storage of macromolecules occurs in 
lysosomes due to multiple lysosomal enzyme deficiencies. Since 
lysosomes are the cellular organelles in which macromolecules are 
degraded, these macromolecules accumulate leading to abnormal 
inclusions in cells such as lymphocytes. Therefore, diagnosis of I cell 
disease can be accomplished by detection of cytoplasm inclusion bodies 
in lymphocytes or cultured skin fibroblasts together with multiple 
lysosomal enzyme activity abnormalities. Several groups[1, 2, 4, 5] have 
investigated the ultrastructural features in I cell disease. A common 
finding in these studies was the various cytoplasm inclusion bodies found 
in several types of cells. Furthermore, these inclusion bodies contained 
macromolecules, which could be stained with Sudan Black B (lipids) and 
periodic acid Schiff (PAS; glycogen)[4]. 
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Here, we describe a peripheral blood smear from a patient with vacuole-
like inclusions in the cytoplasm of lymphocytes, which led to an early 
diagnosis of I cell disease. The diagnosis of I cell was finally confirmed 
by lysosomal enzyme activity measurements in plasma.  
 
 
Case report 
This girl was born after an uneventful pregnancy at 38 weeks gestation 
as the first child of nonconsanguineous Turkish parents. The mother had 
3 miscarriages before at 3 months of gestational age. The birth weight of 
the child was 2330 g. She was dysmorphic at birth, but on request of 
both parents no further investigation was done. At the age of 56 days 
she was admitted to our hospital with severe respiratory insufficiency, 
caused by bronchopneumonia. Artificial ventilation was needed for four 
days. Physical examination revealed the following abnormalities: coarse 
facies, thick eyelids, hypertelorism, low implanted ears, narrow forehead, 
micro- and retrognatia, laterally bowed legs and rocker bottom feet. The 
liver was 3 cm and the spleen was 1 cm palpable. The activity of alkaline 
phosphates in blood was increased to as much as 3240 U/L (reference 
value: up to 350 U/L, age and sex related). Most of the alkaline 
phosphatase originated from the bones. Serum phosphate, serum 
calcium and total protein were decreased (0.78 mmol/L, 1.10 mmol/L and 
47 g/L respectively). 
Haemocytometry of the blood provided a value of haemoglobin, 4.4 
mmol/L; leukocytes, 7.8 x 109/L; and platelets, 172 x 109/L. 
During her stay at the paediatric ward the patient drank poorly and her 
increase in body weight was marginal. After three days she was 
readmitted to the intensive care because of respiratory insufficiency and 
cardiogenic shock. She was treated with digoxin and diuretics. When she 
was clinically stable she was discharged from hospital. From then, the 
parents withdrew her from follow-up. 
 
 
Methods  
Air dried blood smears were stained using standard methods of May-
Grünwald Giemsa, Sudan Black B and PAS. 
Na-citrate blood (3.8% vol/vol) was centrifuged at 750xg for 10 min at 
room temperature. Plasma was decanted and the cells were fixed in 2% 
gluteraldehyde phosphate buffer (140.4 mmol/L NaCl, 13.8 mmol/L 
Na2HPO4, 1.9 mmol/L NaH2PO4: pH 7.4) at 4°C. After three hours the 
buffy coat was removed, sliced and post fixed in 1% osmiumtetroxide for 
one hour at room temperature. After dehydration in graded 
concentrations of alcohol, the blocks were embedded in Epon. The ultra 
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thin sections (80 nm) were contrasted with uranyl acetate and lead 
nitrate and examined with a JEOL 1200 EX/II electron microscope[6]. 
Lysosomal enzyme activities in plasma and fibroblasts were measured 
as described previously[7]. 
 
 
Results 
The blood smear revealed 88% lymphocytes, 8% granulocytes and 4% 
monocytes. Approximately 25% of the lymphocytes were atypical and 
appeared to have grey blue inclusions (size 1-2 µm) with a vague 
azurophilic granulation in the centre (figure 1). 
 
fig 1 
A lymphocyte with many vacuole-like inclusions. The cytoplasm is stained blue, the 
vacuole-like inclusions are stained pink (900x). 
 
In disrupted normal lymphocytes, only a nuclear ghost was visible, 
however in case of disrupted abnormal lymphocytes (a consequence of 
preparing a blood smear), the vacuole-like inclusions were still visible 
(figure 2). These vacuole-like inclusions might suggest a viral infection. 
Staining with Sudan Black B to identify a lipid storage disease and PAS 
to detect a glycogen storage disease gave negative results. 
Electron microscopy of the blood cells revealed a large number (up to 
20) of cytoplasmic vacuoles, some of which had no visible content, 
although most had an aggregation of small globular or possible tubular  
structures. In addition, a round osmiophilic structure was found in most 
cells (figure 3). 
The diagnosis was finally confirmed by the low activities of β-D-
galactosidase (8 nmol/h/mg protein; ref.value: 600-1,500), N-acetyl-β-D-
glucosaminidase (1,715 nmol/h/mg protein; ref.value: 8,000-38,000) and  
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fig 2 
A disrupted cell with around the nuclear remnant, the released inclusions (900x). 
 
 
fig 3 
 Electron microscopic presentation of vacuoles in lymphocytes with the round 
osmiophilic structures (15,000x) 
 
α-D-mannosidase (16 nmol/h/mg protein; ref.value: 200-720) in 
fibroblasts and the high activities of β-D-galactosidase (117 nmol/h/mg 
protein; ref.value: <20), N-acetyl-β-D-glucosaminidase (26,582 
nmol/h/mg protein; ref.value: 900-7,000) and α-D-mannosidase (7,000 
nmol/h/mg protein; ref.value: 50-350) in plasma. These findings are 
characteristic for an I-cell disease. 
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Discussion 
I-cell disease is evident from birth showing a gradual degeneration. The 
disease has an autosomal recessive mode of inheritance. 
Although several authors have described vacuoles or inclusions in the 
lymphocytes of patients with I-cell disease[3, 8, 9], images of both electron 
microscopy and light microscopy were only occasionally presented[10]. In 
our case, the vacuoles appeared to be inclusions. Neutrophils and 
monocytes had a normal appearance in our patient’s blood smears. 
Electron microscopy of the lymphocytes revealed that the inclusion 
bodies had a single membrane and most of them contained an 
osmiophilic structure. However, in contrast to Leroy et al[8], PAS and 
Sudan Black B staining were negative. After disruption of the cells these 
inclusions were clearly visible, whereas in the case of normal 
lymphocytes only a nuclear ghost was visible. 
Although many authors described the I-cell disease, only Koga and co-
workers[3] and Leroy and co-workers[8] have mentioned vacuoles or 
inclusion bodies in blood cells. This report confirms these findings. 
However, in contrast to Koga[3] we did not find vacuoles in neutrophils[3, 
8]. Careful microscopic observation of peripheral blood smears may lead 
to the discovery of rare abnormalities in blood such as intracellular 
metabolite accumulation. The presence of abnormal granulation or 
vacuolisation of lymphocytes can facilitate a rapid diagnosis of some 
inherited metabolic diseases. 
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Abstract 
Spurious platelet counts can be found in acute leukaemia’s, caused by 
fragmentation of blood cells. Microscopic examination of a blood smear 
should be performed to detect the presence of these so-called 
pseudoplatelets. In case of their presence, the platelet count should be 
corrected in time because of the important clinical consequences of this 
finding in these patients. 
K3EDTA anticoagulated blood was measured on an automated blood cell 
counter, and a blood smear was made and stained according the May-
Grünwald Giemsa method for microscopic observation. A 500 
cell/particle differentiation was performed and the automated platelet 
count was corrected. 
We studied the incidence of pseudoplatelets in 169 patients with acute 
leukaemia. Pseudoplatelets were detected in 43 cases (25.4%), and 7 
cases (4.1%) were re-classified as having a major bleeding risk (platelet 
count <15x109/L). 
We emphasize the importance of the morphologic observation of 
platelets in patients with acute leukaemia and the development of a 
routine screening method for the detection of pseudoplatelets. 
 
 
Introduction 
Haemorrhagic diathesis is a common manifestation of acute leukaemia 
and is usually caused by thrombocytopenia[1]. Haemostatic disturbances 
observed in patients with acute leukaemia can be related to changes in 
vascular function, failure of the haematopoietic system, liver dysfunction, 
increased fibrinolysis or disseminated intravascular coagulation (DIC)[2]. 
In such patients, a spurious platelet count due to red cell fragmentation[3] 
or fragmentation of white blood cells[4-11] has been reported previously. 
Stass e.a.[5] reported spurious elevation of automated platelet counts in a 
patient with hairy cell leukaemia, with at the microscopic counting a 
significantly lower number of platelets. Armitage e.a.[6] described a 
patient with acute leukaemia with artificially elevated platelet counts due 
to circulating fragments of leukaemic cells. Malcolm e.a.[7] reported a 
case of spurious thrombocytosis in a patient with acute myelocytic 
leukaemia, with at microscopic observation of the blood smear a 
thrombopenia: The automated platelet count in this patient was ten times 
higher as compared to the microscopic count. Stass e.a.[8] reported a 
case of spurious platelet counts due to cell fragmentation in a patient 
with a poorly differentiated lymphoma: After chemotherapy the number of 
platelet-like fragments increased. Hammerstrom[9] reported a patient with 
a newly diagnosed acute myeloid leukaemia (AML: FAB M5) with DIC for 
which the patient was treated with low dose heparin. Although the 
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platelet count was 129x109/L, the patient developed an intracerebral 
bleeding and died. Staining the blood smears with platelet-specific 
antigen resulted in only 4% positive cell particles, whereas one third of 
the particles showed identical staining characteristics as the leukaemia 
cells, indicating their leukaemic origin. Sugimoto e.a. [10] reported a case 
of AML (FAB M2) with cell fragments resembling giant platelets positive 
for myeloperoxidase. Finally, Li e.a.[11] reported a case with secondary 
acute monocytic leukaemia with tumour lysis syndrome: Numerous 
fragments of leukaemic cells resulted in a falsely elevated platelet count. 
Moreover, apoptotic cells with pycnotic nuclei were seen, suggesting a 
relationship between apoptosis and pseudoplatelets. 
In the present study we investigated 169 patients with leukaemia, both 
de novo diagnosed and relapsed (table 1). Furthermore, we looked at the 
bleeding tendency of patients with pseudoplatelets who are classified 
into the risk group for bleeding disorders after correction of the 
automated platelet count. 
 
table 1. Distribution of leukaemia type, age, onset/relapse and sex in the group of 
169 patients 
 mean age 
(min-max) 
 
Onset/relapse 
 
Male/female 
Total 35 (2-83) 131/38 93/76 
ALL 15 (2-64) 53/7 40/20 
AML-M0 48 (32-79) 1/3 1/3 
AML-M1 53 (9-79) 11/4 9/6 
AML-M2 50 (9-82) 17/1 10/8 
AML-M3 40 (19-59) 10/0 3/7 
AML-M4 51 (14-83) 17/3 13/7 
AML-M5 44 (7-70) 7/3 3/7 
AML-M6 53 1/0 1/0 
AML-M7 26 (2-51) 2/0 0/2 
Not specified 45 (11-75) 12/16 13/15 
 
To exclude that pseudoplatelets are an intrinsic result of slide 
preparation method, both the correlation of pseudoplatelets with smudge 
cells and pseudoplatelets with leukocytosis was studied. 
 
Materials and methods 
Blood was obtained by venapuncture or by finger prick and 
anticoagulated with K3EDTA. Within four hours, the blood was measured 
for complete blood cell count (CBC) and a blood smear was made by the 
wedge method. The slides were stained according the May-Grünwald 
Giemsa method. Stained slides were embedded and stored in a dark 
place at room temperature. 
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CBC was performed by an automated analyser: H*3 from Bayer 
(Tarrytown, USA) or Sysmex NE-8000 from Toa (Kobe, Japan). The 
principle of platelet counting is based on flow cytometry (H*3) or 
impedance (NE-8000). Both platelets and erythrocytes are counted in the 
same channel: discrimination between platelets and erythrocytes is 
made on particle size. 
The patients included in the study were diagnosed with acute leukaemia 
at onset or at relapse with blast cells in the peripheral blood. The various 
types of leukaemia, onset/relapse and age and sex of the patients are 
listed in table 1. The acute leukaemia’s were further specified according 
the FAB-classification[12] with the aid of immunofenotyping and 
cytochemistry. Of each sample a 500 particle differentiation was made 
(platelets, pseudoplatelets, leukocytes and smear cells) and the 
percentage of pseudoplatelets was calculated. In case of high WBC, the 
platelets and pseudoplatelets were counted separately. Arbitrarily, if 
more than 5% pseudoplatelets were present the smear was considered 
positive for the presence of pseudoplatelets. These positive samples 
were also reviewed by an independent expert. Both manual countings 
were averaged out and used to correct the platelet count. As cut off 
value for serious bleeding risk we have used 15x109/L: The mean of 
10x109/L and 20x109/L, as published previously[13, 14]. 
 
Results 
In the blood smears of 43 (25%) out of 169 patients pseudoplatelets 
were found: 32 (30%) smears out of 107 patients with AML and in 11 
(18%) smears of 62 patients with ALL (table 2). The morphology of 
pseudoplatelets was comparable with agranular platelets, but with a 
deeply stained cytoplasm in accordance with the cytoplasm of malignant 
cells (figure 1). Note that in these patients red cell fragments were not 
found. Of this group of 43 patients, a total number of 11 patients was 
retrospectively considered as positive for major bleeding events (table 3). 
The platelet count obtained with a haematology analyser varied from 
10x109/L to 75x109/L in these patients, while the corrected platelet count 
ranges from 2x109/L to 15x109/L, with a mean difference of 20x109/L or 
40%. Two patients with a corrected platelet count of 10x109/L and 
3x109/L were not included because of technically poor blood smears. 
There was no correlation between pseudoplatelets and smudge cells (R2: 
0.14) nor for the pseudoplatelets and leukocytosis (R2: 0.04) (figure 2). 
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table 2. Incidence of the presence of pseudoplatelets in relation with the different 
types of leukaemia 
 
Type 
 
Subtype Total number 
of patients 
Number of patients 
with pseudoplatelets 
Percent
ALL  62 11 18 
AML   107 32 30 
 AML-M0 4 0 0 
 AML-M1 15 5 33 
 AML-M2 18 4 22 
 AML-M3 10 2 20 
 AML-M4 20 3 15 
 AML-M5 10 3 30 
 AML-M6 1 0 0 
 AML-M7 2 0 0 
 Not further specified 28 1 4 
Total  169 43 25 
 
 
fig 1 
Morphologic aspects of pseudoplatelets: 1 AML-M1 with true platelet (a) 
pseudoplatelet (b) and smear cell (c), 2 AML-M5 with three pseudoplatelets and one 
blast cell, 3 AML-M2 with true platelet (a), two pseudoplatelets (b) and two (pro)blast 
cells, 4 ALL with pseudoplatelet budding (arrowhead) of a lymphoblast. 
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Discussion 
Nowadays, haematology analysers are able to produce platelet counts 
with great precision and accuracy. Even in the very low range (below 15 
x 109/ L), the counts are usually reliable. However, in certain cases these 
analysers produce erroneous platelet results. Pseudotrombopenia is a 
well-known phenomenon and via various procedures (e.g. recounting 
platelets in citrated blood) the laboratory is able to produce a correct 
result. We report an opposite phenomenon with important clinical 
implications: pseudothrombocytosis or at least obvious overestimation of 
the real number of platelets in patients with acute leukaemia. Due to their 
shape and size, haematology analysers add a number of undefined 
particles to the platelet cluster. In some cases, this may even lead to the 
masking of a (possible life-threatening) thrombopenia and consequently 
the withholding of proper medication or other crucial supportive 
measures. 
 
table 3 Overview of the patients with a corrected platelet count of 15 x 109/L or less. 
In parenthesis the range is given.  
No 
 
Type Age/sex Automated platelet 
count x 109/L 
 
Corrected platelet count 
x 109/L (range) 
1 ALL 43/m 10 2 (1-2) 
2 AML-M1 44/m 24 12 (10-13) 
3 AML-M1 55/m 57 14 (12-16) 
4 AML-M1 9/m 10 6 (5-6) 
5 AML-M1 63/m 28 14 (10-18) 
6 AML-M2 74/v 75 15 (10-20) 
7 AML-M2 46/m 13 8 (7-9) 
8 AML-M2 81/v 48 8 (5-10) 
9 AML-M3 22/v 23 14 (12-16) 
10 AML-M5 56/v 14 8 (7-9) 
11 AML-M5 24/m 21 9 (9) 
 
 
The undefined particles (or pseudoplatelets) are not formed due to 
mechanical destruction during the preparation of the smear. No 
correlation was found between the number and presence of smudge 
cells and the number and presence of pseudoplatelets, indicating a 
different origin. 
To establish a proper platelet count, we suggest that the blood smears at 
presentation and at unexpected bleeding disorders in patients with acute 
leukaemia (de novo or relapsed) should be examined for 
pseudoplatelets. In the presence of pseudoplatelets, the automated 
platelet count should be corrected. In the present study, in more than 
25% of the described patients the platelet counts had to be corrected. As 
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in almost 5% of the patients this resulted in a re-classification of the 
bleeding risk, the finding of pseudoplatelets has important consequences 
for the clinical management of patients with acute leukaemia.  
pseudoplatelets versus smear cells
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Correlation of pseudoplatelets with smear cells and WBC 
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Abstract 
This study reports the design of an immunofluorescent method for the 
co-determination of neutrophil CD64 (PMN-CD64), monocyte CD64 
(MON-CD64) and monocyte HLA-DR (MON-Ia) expression with the Cell-
Dyn CD4000 haematology analyser. Normal PMN-CD64, MON-CD64 
and MON-Ia expression, defined as the mean +2SD of 25 healthy adults 
after correction for isotype control staining, corresponded to 17-67, 515-
1045 and 170-670 AFU, respectively. Analytical reproducibility 
determined by duplicate analysis of 12 random samples revealed good 
assay consistency for all three analysed antigens, with day to day 
variation in normal subjects being relatively minor in significance.  
CD4000 PMN-CD64 values showed a good correlation with flow 
cytometry although short term (12 hours) stability studies suggested an 
in vitro trend for increasing PMN-CD64 antigen expression with 
progressive storage.  Observed ranges of PMN-CD64, MON-CD64 and 
MON-Ia for 109 randomly-selected clinical samples were 31-1058, 307-
2843 and 10-876 AFU. Abnormal PMN-CD64 and MON-CD64 shared 
the same trend (upregulation) while abnormal monocyte MON-Ia was 
characterised by declining expression. Normal PMN-CD64 was only 
seen with normal (45/52) or intermediate (7/52) MON-CD64, while high 
PMN-CD64 was mostly associated with intermediate (18/22) or high 
(3/22) MON-CD64. MON-Ia expression was largely independent (p=0.04) 
of PMN-CD64 although marked decreases in MON-Ia were invariably 
associated with intermediate or high PMN-CD64. MON-Ia expression 
was inversely related (p<0.0001) to absolute granulocyte counts, and 
patients with high PMN-CD64 were more likely (8/25) to have in excess 
of 10% band cells compared to samples with normal/intermediate PMN-
CD64 (0/84). When compared to C-Reactive Protein (CRP), high PMN-
CD64 and MON-CD64 were always associated with an increased CRP 
concentration, but minor proportions of samples with normal PMN-CD64 
(11/52) or normal MON-CD64 (11/65) could also have an increased 
CRP. The procedures described in this communication overcome a 
number of limitations associated with flow cytometry, and co-
determination of CD64 and HLA-DR antigen expression may provide 
additional insights into patient heterogeneity in the assessment of 
suspected sepsis compared to CD64 analysis alone. 
 
 
Introduction 
There are many reports regarding the potential of measuring neutrophil 
membrane CD64 (PMN-CD64) for the diagnostic assessment of sepsis[1-
6]. The membrane molecule defined by monoclonal antibody CD64 is a 
high-affinity receptor (FcγRI) found on normal monocytes and is only 
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expressed at low levels by normal neutrophils. Upregulation and 
increased expression of PMN-CD64 appears to be a sensitive marker for 
early-onset clinical infection in newborn children[6-7], and in adults its use 
has been variably suggested for differentiating systemic infection from 
active inflammatory disease[8], monitoring γ-interferon therapy[2] and as 
an indicator for initiating or discontinuing antibiotic treatment[6]. PMN-
CD64 analysis may be particularly useful for assessing sepsis in young 
children and elderly patients, where haematological parameters such as 
leukocyte/granulocyte counts, or the presence of immature granulocytes 
and band cells are relatively uninformative[9-11] and for investigating 
patients with primary disturbances in neutrophil numbers associated with 
haematological malignancies or myelosuppressive therapies. All studies 
to date of PMN-CD64 expression have been performed by flow 
cytometry using fluorochome-monoclonal antibody conjugates. However, 
a more efficient approach would be to develop a procedure whereby 
EDTA-anticoagulated blood samples submitted for FBC analysis could 
be directly processed for PMN-CD64 as a supplementary procedure by 
the haematology laboratory. The first aim this study was therefore to 
examine whether or not a method for the simultaneous measurement of 
PMN-CD64 and monocyte CD64 (MON-CD64) could be potentially 
implemented on a routine haematology analyser (Cell-Dyn CD4000; 
Abbott Diagnostics, Santa Clara, CA, United States). As part of the 
method design, a second marker (HLA-DR) was included because (in 
contrast to CD64) its expression by monocytes is reportedly decreased 
in patients with sepsis[12-14]. Supplementary aims of this study were 
therefore to determine relationships between relative PMN-CD64 
expression and the levels of MON-CD64 and MON-Ia in a randomly-
selected series of patient samples where clinical requests for C-Reactive 
Protein (CRP) had been made, and to examine pattern heterogeneity of 
CD64/HLA-DR antigen expression in comparison with CRP 
concentration and absolute granulocyte count. 
 
 
Materials and methods 
CD4000 Analysis of Neutrophil and Monocyte Membrane CD64/HLA-DR: 
In addition to the standard full blood count (FBC) configuration, the 
CD4000 optical bench has the capability of measuring FL1 and FL2 
fluorescence. These are integrated into a specific assay processing 
routine for the enumeration of CD3+CD4+ and CD3+CD8+ populations [15]. 
The method used for the co-determination of PMN-CD4, MON-CD64 and 
MON-Ia expression was based on an adaptation of the CD4000 
automated CD3/4/8 assay. In essence, the two reaction vials (CD3/CD4 
and CD3/CD8) normally used for the CD3/4/8 counts of a single sample 
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were substituted with non-anticoagulated Vacutainer tubes containing 
100µL whole blood plus 20µL anti-CD64/FITC (IgG1 subclass; Becton 
Dickinson) and 15µL anti-HLA-DR/PE (IgG2a subclass; Becton 
Dickinson). The two tubes were processed using the CD4/CD8 assay 
mode after preliminary incubation at room temperature for 10 min. 
Antibody-blood ratios were obtained following preliminary titration studies 
to confirm saturating antibody concentrations, and in this assay 
configuration the two tubes corresponded to identical CD64/HLA-DR 
analyses for two different patient samples. On completion of instrument 
blood sampling and data acquisition (List Mode enabled), raw data files 
were downloaded to a PC and batch-converted to standard FCS2.0 
format with Cell-Dyn Clinical Data Standard (CDS) converter software 
(CDS Office Suite; Abbott Diagnostics Cell-Dyn R&D Department, 
Europe) prior to population analysis. This ‘in-house’ software was 
designed to generate single-dilution FCS files, readable by standard FCS 
software/freeware, because Cell-Dyn systems produce multiple files (for 
each part of instrument analysis) that are stored within a single List Mode 
file. Converted List Mode files from the CD4000, typically comprising 12k 
to 20k individual events, allow generation of multiple plot types with 
parameter options being 7o Intermediate Angle Scatter, 0o Axial Light 
Loss (size), FL1, FL2 and FL3. 
 
Samples Studied: 
To determine control ranges for neutrophil and monocyte antigen 
expression for the CD4000 method, 25 samples were collected from 
normal healthy adult volunteers. Supplementary studies were also 
undertaken to define methodological limitations. Assay reproducibility 
was determined by duplicate analysis of 12 randomly selected samples, 
and stability of PMN-CD64 antigen expression during sample storage 
was assessed by analysing 12 EDTA-anticoagulated samples at 1, 6 and 
12 hours after collection. In addition, day to day variation in individual 
normal subjects was determined by examining neutrophil and monocyte 
antigen expression with samples from 9 healthy volunteers collected 
three days apart, and the CD4000 method for PMN-CD64 antigen 
quantitation was compared with a flow cytometry procedure by analysis 
of 12 further samples. The flow cytometry method (Beckmann Coulter 
Epics XL) involved incubation of EDTA anticoagulated blood samples 
with monoclonal antibodies for 15 minutes, erythrocyte lysis with 0.15M 
ammonium chloride for 10 minutes, washing and cell resuspension. 
Using 90o side-scatter and CD45-ECD/CD14-PE/Cy5 fluorescence 
(Trillium Diagnostics LLC, Maine USA) granulocytes were gated and 
monocytes excluded. By means of parallel analysis with CD64-FITC and 
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CD163-PE (Trillium Diagnostics), granulocytes were defined as CD64+ 
when fluorescent staining exceeded the first log decade. 
 
To further understand the relationships between PMN-CD64, MON-
CD64 and MON-Ia expression, a series of 109 EDTA-anticoagulated 
patient samples were analysed within 6 hours of venesection (after 
storage at ambient temperature). These were randomly selected from 
the routine haematology workload and comprised patients for whom 
turbidimetric measurements of C-reactive Protein (CRP) had been 
clinically requested on the same day. Full blood counts were obtained 
with the CD4000 analyser, and stained blood films were reviewed to 
determine the morphological differential (including percentages of band 
cells and Immature Granulocytes). In addition, leukocyte integrity was 
assessed using the automated CD4000 propidium iodide staining 
procedure[16] and all samples showed >98% viability. 
 
Statistical Analysis:  
Relationships between individual measured parameters were variously 
analysed by logarithmic plots, Passing & Bablok[17] agreement and the 
Chi-square test (Analyse-It Software Ltd, PO Box 103, Leeds, England). 
 
 
RESULTS 
Methodological Procedures:   
Gating of neutrophil and monocyte populations (figure 1) with WINMDI 
flow cytometry software (http://facs.scripps.edu/software.html) was 
facilitated by primary separation of all collected leukocyte events into 
HLA-DR+ and HLA-DR- fractions (FL1 versus FL2 plot). Region setting 
for the neutrophil population was then based on the morphological 
discrimination of HLA-DR- events in the CD4000 optical (0o versus 7o) 
plot.  Monocytes were defined as the HLA-DR+ population (irrespective of 
the actual level of expression) within the upper area of the CD4000 
MAPSS 0o versus 7o plot. After region setting, all events associated with 
each defined leukocyte fraction were analysed in FL1 and FL2 
histograms (4-decade log) to obtain the median and geometric means of 
CD64 and HLA-DR staining intensities (figures 2 and 3). As these were 
numerically similar for all tested samples, the median value, expressed 
as arbitrary fluorescent units (AFU) was subsequently used for all 
comparative measurements. Isotype controls were used to determine 
‘background’ fluorescence for each cell population and this was 
deducted from the median values of sample fluorescence prior to 
comparative analysis. In addition, FL3 staining (propidium iodide) 
automatically included in the analytical process by the CD4000[16] was 
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assessed to confirm that all studied samples had high (>98%) leukocyte 
viability and no evidence of sample deterioration. 
 
fig 1 
Gating procedure for discrimination of neutrophil and monocyte populations. All 
leukocyte events were examined in an CD64/FL1 versus HLA-DR/FL2 plot (a) and a 
region set for the HLA-DR+ fraction. The events were then redisplayed in the CD4000 
0o (Size) versus 7o (Complexity) plot (b) and the HLA-DR- events excluded (c). A 
second region (purple) was set around the larger sized monocyte fraction and the 
other HLA-DR+ events (predominantly B-cells) excluded (d). The resulting gated 
monocyte fraction was then used for the semi-quantitative determination of CD64 
(MON-CD64) and HLA-DR (MON-Ia) expression. The neutrophil fraction was defined 
by excluding HLA-DR+ events in plot (b) to leave two residual populations (e). A 
further region gate (orange) was applied to the cluster with the higher Size and 
Complexity profile and the other HLA-DR- events (predominantly T-cells) excluded. 
The resulting neutrophil fraction was then used for the determination of CD64 (PMN-
CD64) expression. 
 
Preliminary assessment of FL1 and FL2 data for files with and without 
fluorescent channel compensation revealed that crossover of FL1 
fluorescence (CD64) into the FL2 channel (HLA-DR) had no significant 
effect on semi-quantitative levels of HLA-DR staining. Therefore in order 
to simplify the procedure, non-compensated files were used for statistical 
determinations of median antigen staining. 
Control Neutrophil and Monocyte Antigen Expression  
Histogram profiles of PMN-CD64 staining intensity showed a normal 
distribution, and analysis of the 25 normal samples revealed a mean 
PMN-CD64 of 98 AFU (observed range 83-126). Parallel analyses with 
an IgG1 isotype control reagent indicated background levels of 56 AFU 
and this value was subsequently deducted from all PMN-CD64 
determinations. Based on the corrected control values (observed minus 
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fig 2 
Examples of gating procedures and subsequent determination of PMN-CD64 
expression. The upper series of samples (1a to d) are for a normal sample with PMN-
CD64 staining of 102 AFU while the lower series (2a to 2d) are for a sample with 
markedly increased PMN-CD64 of 278 AFU. The neutrophil population gating 
procedure is as detailed in Figure 1 and Results, and the distribution of CD64 
staining intensities are shown in histogram form (1d and 2d). While the neutrophil 
morphological characteristics of the two samples are similar (1b and 2b), the 
increased expression of CD64 in sample 2 is clearly seen as an extended profile on 
the CD64 (FL1) axis (2c and 2d). Note the minor tendency for cross-channel 
fluorescence from FL1 (CD64 axis) into FL2 (Ia axis) at higher levels of PMN-CD64 
expression in plot 2c. 
 
fig 3   
Neutrophil CD64 (PMN-CD64), monocyte CD64 (MON-CD64) and monocyte HLA-
DR (MON-Ia) histogram staining profiles. The three examples shown in histogram (a) 
show (uncorrected for isotype controls) median PMN-CD64 staining levels of 90 AFU 
(solid), 166 AFU (dotted) and 722 AFU (continuous) and correspond to normal, 
intermediate and high PMN-CD64 staining categories respectively. Histogram (b) 
shows samples with normal (solid, 673 AFU), intermediate (dotted, 1433 AFU) and 
high (solid, 2371 AFU) monocyte CD64 (MON-CD64) expression. Histogram (c) are 
examples with normal (solid, 542 AFU) and intermediate decrease (dotted, 184 AFU) 
and markedly decreased (continuous, 81 AFU) monocyte HLA-DR (MON-Ia) 
expression. Note the normal distributions of staining for PMN-CD64 and MON-CD64 
compared to the non-normal staining pattern for MON-Ia, and the existence of MON-
Ia subpopulation heterogeneity. 
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background), the normal range for PMN-CD64 defined as the mean + 
2SD (Standard Deviation) corresponded to 17 to 67 AFU. A high level of 
PMN-CD64 expression (>135 AFU) was therefore defined as a PMN-
CD64 value exceeding twice the upper normal limit, while an 
intermediate increase represented PMN-CD64 expression between 67 
and 135 AFU. Using a similar approach for deriving normal MON-CD64, 
normal, intermediate and high MON-CD64 expression were respectively 
defined as 515 to 1045, 1046 to 2090 and >2090 AFU after correction for 
background (isotype control) fluorescence. 
 
In contrast to neutrophil and monocyte CD64, where abnormal trends 
were associated with antigen upregulation, abnormal monocyte HLA-DR 
(MON-Ia) was characterised by declining expression. Thus, the isotype-
corrected normal range (mean +2SD) for 25 normal samples 
corresponded to 170 to 670 AFU, while a marked decrease was defined 
as less than 50% of the lower normal limit (<85 AFU) and an 
intermediate decrease as MON-Ia values between 85 and 170 AFU. 
 
Methodological Variables: 
Analytical reproducibility was determined by duplicate analysis of 12 
random patient samples. Of these, all were evaluable for PMN-CD64 
expression and all but one were evaluable for MON-CD64 and MON-Ia 
expression. The single sample that could not be analysed had very high 
PMN-CD64 expression (580 AFU) with severe monocytopenia and too 
few monocyte events for reliable analysis. The results of these duplicate 
studies (figure 4) revealed a high level of assay consistency for all three 
analysed antigens. 
Stability of PMN-CD64 antigen expression during sample storage was 
assessed by analysing 12 EDTA-anticoagulated samples at 1, 6 and 12 
hours after collection. Although there was some individual sample 
variability, an apparent trend was nevertheless observed.  At 1 hour, the 
mean PMN-CD64 expression was 63.7 AFU and this was normalised to 
represent a 100% baseline level. At 6 hours, the mean change was +5% 
(range -7% to +26%) and at 12 hours the mean change was +16% 
(range 0% to +47%). Further examination of the data revealed that there 
was no significant decrease in neutrophil viability during the 12 hour 
period. 
 
Day to day variation in normal individuals was determined by examining 
neutrophil and monocyte antigen expression with samples from 9 healthy 
volunteers collected three days apart. The results (figure 5) indicated that 
for PMN-CD64 expression, 8/9 showed similar assay values within the 
normal control range. Only one subject showed a significant difference 
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with a PMN-CD64 of 139 AFU (intermediate increase) on day 1 
compared to 67 AFU (normal) on day 3. Similar day to day consistency 
was also seen with MON-CD64 and MON-Ia, with only one individual in 
each group showing higher expression on day 1 compared to day 3. 
Correlation between the CD4000 method and the flow cytometric 
procedure was assessed by parallel analysis of 12 randomly selected 
samples. Although the methods differed in the way the data was 
fig 4 
Duplicate analysis of 12 randomly selected samples for PMN-CD64, MON-CD64 and 
MON-Ia expression. For each tested sample, two separate tubes were stained and 
processed, with the levels of antigen expression (AFU) being determined as detailed 
in the text. The paired measurements for MON-CD64 and MON-Ia expression 
exclude one sample with severe monocytopenia where there were too few events for 
reliable analysis. 
 
 
fig 5 
Day to day consistency of PMN-CD64 (solid circles), MON-CD64 (open circles) and 
MON-Ia (solid triangles) expression. Nine healthy subjects were venesected on two 
separate occasions three days apart and assayed for all three antigens with the 
CD4000 method. Normal ranges are shown as boxed rectangles, with the data 
indicating generally good stability of antigen expression. Outliers, corresponding to 
one of the nine subjects in each of the assay groups, are seen to slightly exceed 
normal limits on day 1 only of the comparative analyses. 
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reported, a point which is considered in more detail in the Discussion, 
there was nevertheless a good correlation with higher CD4000 AFU 
values being associated with higher percentages of CD64+ neutrophils 
(figure 6). 
 
fig 6   
Comparison of the CD4000 method for PMN-CD64 expression (Log10 AFU) and flow 
cytometry (percentage CD64+ neutrophils as defined in Materials and Methods) for 
12 analysed samples. Although the methods of reporting for the two procedures were 
different, a good level of correlation (logarithmic trendline) is clearly seen. 
 
Patterns of Neutrophil and Monocyte CD64 and HLA-DR Antigen 
Expression: 
Observed ranges of PMN-CD64, MON-CD64 and MON-Ia for the 109 
clinical samples were 31 to 1058 AFU, 307 to 2843 AFU and 10 to 876 
AFU respectively. Membrane antigen data were obtained for all but three 
samples with severe monocytopenia. PMN-CD64 and MON-CD64 
expression shared the same overall trend although relative increases in 
MON-CD64 expression were higher than PMN-CD64 (figure 7a). More 
detailed examination of individual samples (table 1) showed that normal 
PMN-CD64 expression was only seen with normal (45/52) or 
intermediate MON-CD64 (7/52), while high PMN-CD64 was usually 
associated with intermediate (18/22) or high (3/22) MON-CD64. By 
comparison, MON-Ia expression appeared to be largely independent 
(p=0.04) of PMN-CD64 (figure 7b) although a marked decrease in MON-
Ia was always associated with intermediate or high levels of PMN-CD64 
(table 1). Interestingly, marked decreases in MON-Ia were not seen 
when MON-CD64 was expressed at high levels. 
 
Patterns of Antigen Expression and Granulocyte Counts: 
Evaluated relationships with absolute granulocyte counts suggested 
(table 2) some association with PMN-CD64 expression but none with 
MON-CD64. There was also an inverse relationship (p<0.0001) between 
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fig 7  
Individual sample (n=106) relationships between median neutrophil CD64 and (a) 
monocyte CD64 and (b) monocyte HLA-DR (Ia). Plotted trendlines are derived from 
logarithmic plots. 
 
MON-Ia and the absolute granulocyte count with a trend for higher 
counts with decreasing membrane HLA-DR expression. Examination of 
other haematological parameters revealed no significant association 
between neutrophil and monocyte antigen levels and percentages of 
Immature Granulocytes (data not shown), although samples with high 
PMN-CD64 were more likely (8/25) to have in excess of 10% band cells 
compared to samples with normal or intermediate PMN-CD64 (0/84).  
 
Patterns of Antigen Expression and CRP Concentration:   
The range of CRP concentrations for the 109 clinical samples analysed 
in this study was <10 to 460 mg/L. There were 57 samples with a normal 
CRP (<10 mg/L), 49 between 10 and 100 mg/L, and 3 with 
concentrations higher than 100 mg/L. When neutrophil and monocyte 
antigen expression was compared to CRP (table 3), high degrees of 
overall association were observed although individual sample variation 
was also evident. For example, while high PMN-CD64 and high MON-
CD64 expression were always associated with an increased CRP 
concentration, this could also be seen when PMN-CD64 (11/52) and 
MON-CD64 (11/65) were normal. Similarly, 11/15 and 9/10 of the patient 
samples with intermediate or marked decreases in MON-Ia had 
increased CRP levels. Of note with respect to the analysis of monocytes 
was that the three samples with severe monocytopenia (and insufficient 
population events to determine antigen expression) all had CRP 
concentrations exceeding 200mg/L. 
 
 
Discussion 
The primary aim of this study was to evaluate a two-colour 
immunofluorescent assay for leukocyte CD64 and HLA-DR membrane 
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table 1 Relationships between PMN-CD64 , MON-CD64 and MON-Ia expression for 
106 randomly selected clinical samples. Normal, intermediate and high antigen levels 
as defined in Results. Data excludes three samples with severe monocytopenia. 
Monocyte CD64 
Normal Intermediate High 
Neutrophil CD64    
Normal 45 7 0 
Intermediate 19 13 0 
High 1 18 3 
X2 statistic, 48.9 (p<0.0001) 
 
Monocyte Ia 
Normal Intermediate 
Decrease 
Marked 
Decrease 
Neutrophil CD64    
Normal 46 6 0 
Intermediate 23 5 4 
High 12 4 6 
X2 statistic, 15.7 (p=0.04) 
 
Monocyte Ia 
Normal Intermediate 
Decrease 
Marked 
Decrease 
Monocyte CD64    
Normal 57 5 3 
Intermediate 21 10 7 
High 3 0 0 
X2 statistic, 15.0 (p=0.005) 
 
table 2 Relationships between neutrophil (CD64) and monocyte (CD64 and Ia) 
antigen expression and absolute granulocyte counts for 109 randomly selected 
clinical samples. Ranges for absolute granulocyte counts represent multiples of the 
upper normal range (8.0 x 109/L). Normal, intermediate and high antigen levels as 
defined in Results; monocyte antigen data excludes three samples with severe 
monocytopenia. 
Absolute Granulocyte Count (x 109/L) 
<8.0 8.0 - 16.0 >16.0 
Neutrophil CD64    
Normal 42 10 0 
Intermediate 17 14 1 
High 16 5 4 
X2 statistic, 17.0 (p=0.002) 
 
Absolute Granulocyte Count (x 109/L) 
<8.0 8.0 - 16.0 >16.0 
Monocyte CD64    
Normal 51 13 1 
Intermediate 20 14 4 
High 2 1 0 
X2 statistic, 9.2 (p=0.06) 
 
Absolute Granulocyte Count (x 109/L) 
<8.0 8.0 - 16.0 >16.0 
Monocyte Ia    
Normal 62 19 0 
Intermediate Decrease 10 5 0 
Marked Decrease 1 4 5 
X2 statistic, 55.0 (p<0.0001) 
 
markers on a routine haematology analyser with fluorescent capabilities. 
These two antigens are of particular interest because of the considerable 
accumulated evidence suggesting that upregulation (neutrophil and 
monocyte CD64) and downregulation (monocyte HLA-DR) have a 
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consistent association with sepsis. While further substantiating these 
associations was not the purpose of this study, our evaluation of antigen 
expression in 109 randomly-selected samples with clinical requests for 
CRP did allow us to undertake supplementary studies into patterns of 
antigen change and their relationships with both CRP concentration and 
absolute granulocyte count. The value of these additional analyses was 
to highlight the existence of heterogeneous patterns of antigen 
expression compared to these widely-used empirical assessments of 
inflammation/infection. 
 
table 3 Relationships between neutrophil (CD64) and monocyte (CD64 and Ia) 
antigen expression and C-Reactive Protein (CRP) concentrations for 109 randomly 
selected clinical samples. Ranges for CRP concentrations correspond to mild, 
moderate and severe inflammatory processes as defined by Whicher (18). Normal, 
intermediate and high antigen levels as defined in Results; monocyte antigen data 
excludes three samples with severe monocytopenia and CRP levels exceeding 
100mg/L. 
 
CRP (mg/L) 
<10 10 - 50 51 - 100 >100 
Neutrophil CD64     
Normal 41 8 3 0 
Intermediate 16 6 10 0 
High 0 2 20 3 
X2 statistic, 62.1 (p<0.0001)  
 
CRP (mg/L) 
<10 10 - 50 51 - 100 >100 
Monocyte CD64     
Normal 54 8 3 na 
Intermediate 3 8 27 na 
High 0 0 3 na 
X2 statistic, 67.3 (p<0.0001)  
 
CRP (mg/L) 
<10 10 - 50 51 - 100 >100 
Monocyte Ia     
Normal 52 11 18 na 
Intermediate Decrease 4 4 7 na 
Marked Decrease  1 1 8 na 
X2 statistic, 19.8 (p<0.001)  
 
The methodological procedure evaluated in this study was analogous to 
standard flow cytometry in that EDTA-anticoagulated blood samples 
were pre-incubated with FITC/PE-labelled monoclonal antibodies, 
analysed in a laser-illuminated optical system with fluorescent detectors, 
and the resulting raw-file information processed with cytometry software 
to determine the nature of specific cell populations. Compared to flow 
cytometry, the CD4000 analysis is simpler in that instrument calibration 
and gain setting is continuously maintained for the purposes of routine 
blood count analysis. Processing of pre-stained samples, subsequent 
data acquisition (up to 20,000 leukocyte events) and red cell lysis are 
also part of the automated procedure. There is also no need for washing 
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and the method has the additional advantage that the simultaneous 
leukocyte viability measurements [16] provided by the CD4000, minimise 
potential inconsistencies of antigen measurements that may be 
associated with leukocyte population deterioration. Data processing 
using a PC is relatively straightforward and can be achieved in various 
ways. In this study, downloaded CD4000 List Mode files were converted 
to standard FCS2.0 format and analysed using WINMDI software. 
Alternatively, files can be analysed using programmes such as FCS 
Express v3 (De Novo Software, Thornhill, Ontario, Canada) which open 
CD4000 files directly without the need for FCS conversion. 
 
Normal ranges for PMN-CD64, MON-CD64 and MON-Ia were defined by 
analysis of 25 normal adults and the CD4000 method was shown to have 
good duplicate precision and agreement with a flow cytometry 
procedure. Some day to day variation was however noted in some 
individuals but the observed quantitative differences were of minor 
interpretative significance. One potentially important observation 
however was that storage of EDTA-anticoagulated samples for more 
than 6 hours at room temperature could lead to increases in apparent 
PMN-CD64 expression. Although there was significant individual sample 
variation, there was a mean +16% increase in antigen staining at 12 
hours compared to that obtained 1 hour after venesection. As there was 
no evidence that the observed increased expression was associated with 
changes in leukocyte viability, we conclude that this could be due to low-
level in vitro activation or progressive exposure of cryptic CD64 antigens 
during the early stages of leukocyte biological deterioration. 
 
Membrane CD64/HLA-DR antigen levels were semi-quantitatively 
expressed as arbitrary fluorescent units (AFU) in a similar way to many 
previous research and validation studies. This approach was taken as 
the alternative practice of reporting antigen expression as percentages of 
cells exceeding a defined fluorescence threshold are limited. This is 
illustrated in figure 8 which shows PMN-CD64 results of the 109 clinical 
samples as both AFU and percentages CD64+ positive neutrophils 
(where the discrimination threshold was set at a level corresponding to 
the upper 95% distribution of 10 normal control samples). While there is 
a very good overall correlation, the method of determining AFU is more 
informative in terms of detecting differences at very low and very high 
levels of expression and could be important for serial patient monitoring. 
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fig 8 
Comparison of alternative reporting methods for PMN-CD64 expression. The 109 
clinical samples analysed in this study were processed with the CD4000 to determine 
both the quantitative level of antigen expression (AFU) and the percentages of 
CD64+ neutrophils where the fluorescence threshold used to discriminate between 
negative and positive was set at the upper 95% percentile of PMN-CD64 expression 
by 10 normal samples. Plot (a) shows the comparison for all samples while plot (b) 
shows the comparison for samples with lower PMN-CD64 expression of <200 AFU.   
 
While the CD4000 method of antigen quantitation described in this study 
was considered adequate in terms of preliminary method design, and for 
making relative comparisons of antigen density, we accept that this is not 
ideal with respect to the need for standardising inter-institutional 
reporting practices. In this context, improvements in data standardisation 
can be achieved by quantifying antigen molecules per cell[6, 19] or by 
reference to internal fluoresceinated control (calibration) particles[20, 21]. 
With specific respect to neutrophil CD64 measurements, this latter 
principle is utilised by the Leuko64TM assay kit (Trillium Diagnostics LLC, 
Maine USA). This approach goes some way to ensuring consistency of 
antibody reagent source and fluorochrome-protein characteristics of 
monoclonal antibody conjugates but it is important to note that 
fluoresceinated particles do not confirm whether or not leukocytes are 
optimally stained. 
 
As indicated earlier, there is considerable support and clinical evidence 
for using measurements of neutrophil CD64 expression in assessing 
patients with suspected sepsis[1-8]. In vitro observations further 
substantiate this contention in that upregulated expression of PMN-CD64 
is mediated by lipopolysaccharides[22], γ-interferon[23] and G-CSF[24]. In 
contrast to a number of other potential leukocyte markers for sepsis, 
PMN-CD64 has a number of potential practical advantages in that it is 
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expressed at very low level by normal neutrophils and is relatively 
insensitive to sample manipulation[2, 25]. Similarly, the measurement of 
monocyte HLA-DR expression has also been widely evaluated and 
shown to be significantly decreased in sepsis[12, 14, 26] and associated with 
transient immunosuppression[13]. The combined analysis of CD64 and 
HLA-DR, two markers which show opposite trends of upregulation and 
downregulation in sepsis, may be advantageous compared to single 
antigen assessments and a supplementary aim of this study was 
therefore to examine antigen pattern heterogeneity in a series of 109 
patients in relation to two commonly used indicators (CRP and absolute 
granulocyte count) of inflammation/infection. As such, this study is the 
first to specifically assess relationships between PMN-CD64, MONM-
CD64 and MON-Ia for individual samples. 
 
The results showed that while neutrophil and monocyte CD64 
upregulation appeared to follow a similar trend, relationships with MON-
Ia expression were more complex. Significant reductions in MON-Ia are 
characteristically seen in early sepsis, with progressive reattainment of 
normality as sepsis-associated transient immunosuppression is 
overcome[25], and our observations showed that while markedly 
depressed monocyte HLA-DR expression was associated with high 
PMN-CD64 this was in contrast to MON-CD64 which was either normal 
or only moderately increased. The possibility that these different trends 
were to some extent a reflection of differences in cell population kinetics, 
where the half-life of neutrophils (6-9 hours) is considerably shorter than 
monocytes (8-72 hours), and differential cellular responses to 
inflammation/infection is supported by a number of further observations.  
For example, all five patients with absolute granulocyte counts exceeding 
16.0 x 109/L showed markedly reduced MON-Ia expression. Four of 
these showed a consistent pattern of high PMN-CD64, intermediate 
MON-CD64 and high (>100mg/L) CRP concentrations. In contrast, the 
fifth patient showed an intermediate increase in PMN-CD64, normal 
MON-CD64 and a normal CRP. Interestingly, this particular patient who 
was being artificially respirated and had a long history of intermittent 
septic episodes showed a significant increase in CRP in the immediate 
period following antigen testing. An additional finding was that the 
samples with profound monocytopenia all had very high PMN-CD64 
expression and CRP concentrations. 
 
In summary, this study has demonstrated the design feasibility of a 
fluorescent method for the semi-quantitative determination of neutrophil 
(CD64) and monocyte (CD64 and HLA-DR) antigens associated with the 
assessment of sepsis. The combined use of CD64 and HLA-DR is 
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considered more informative than using CD64 alone, and while 
standardisation of the process could be improved by method 
modifications with respect to fluorescent quantitation, the procedure 
nevertheless remains simple and relatively straightforward to implement 
on analysers with fluorescence detection capability. We believe that the 
procedures described in this communication could overcome a number 
of limitations associated with flow cytometry and provide a potential 
indicator of sepsis at relatively low cost and with a minimum of technical 
expertise. 
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Abstract 
Background 
CD64 is a high affinity neutrophil CD64 FcγRI receptor expressed by 
activated neutrophils that has been recently evaluated as a potential 
sepsis parameter. In the present study, the kinetics of neutrophil 
membrane CD64 expression was examined during a standardized 
inflammatory response, using a human endotoxemia model, and 
compared with haematological indices, CRP, cytokines and interleukins. 
Methods 
Ten healthy subjects received 2 ng/kg intravenous E. coli 
lipopolysaccharide (LPS). Neutrophil CD64 expression was measured 
and quantitated with a routine haematology analyser (Abbott Cell Dyn 
4000) using supplementary software. Haematological indices and CRP 
were measured with standard laboratory methods, and cytokines 
determined with simultaneous Luminex Assays. 
Results 
After the administration of LPS, neutrophil CD64 showed a biphasic 
response. The first increase was seen after 1 hour, while the second 
increase started after 6 hours and reached its maximum at 22 hours. For 
the absolute neutrophil count and the immature granulocytes a rapid 
decline was observed followed by an increase with a peak value at 12 
hours. CRP concentrations showed a slow response starting at 6 hours 
and reaching their highest levels 22 hrs after the administration of LPS. 
The cytokines and interleukins reached their maximum response within 
1-2 hours. The maximum values of pro-inflammatory cytokines correlated 
with the CD64 expression at 22 hours after LPS administration, whereas 
this correlation was not found for the anti-inflammatory IL-10. 
Conclusion 
During experimental human endotoxemia, neutrophil CD64 expression 
shows a biphasic response. The correlation between the early release of 
pro-inflammatory cytokines and CD64 expression suggests that CD64 
expression is a quantitative marker of innate immunity. 
 
 
Introduction 
The annual incidence of sepsis in the United States is 50-95 cases per 
100,000 with approximately 9% being categorized as severe and 3% 
complicated by septic shock[1]. As mortality increases with progressive 
sepsis, its early detection is very important.  One of the central features 
of the host response to bacterial infection is the recruitment and 
activation of neutrophils, typically manifested by blood neutrophilia. Other 
haematological indicators of infection include the morphological 
presence of neutrophils with toxic changes (e.g. hypergranulation and 
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Dohle bodies), increased proportions of non-segmented or band 
neutrophils and circulating immature granulocytes (metamyelocytes and 
myelocytes)[2]. However, the non-specific range of diverse conditions 
associated with changes in neutrophil counts[3], as well as the frequent 
occurrence of mild to moderate neutropenia in the acute phase of 
infection and the statistical and morphological limitations of band cell 
enumeration[4-6], considerably limits their diagnostic specificity.  
In addition to haematological investigations, a number of biochemical 
and immunological analyses are variously used as diagnostic aids. 
These include acute phase proteins such as c-reactive protein (CRP) 
and procalcitonin (PCT), cytokines such as tumour necrosis factor-α 
(TNF-α) and interferon-γ (IFN-γ), and interleukins such as IL-6 and IL-
10[7-12]. While many of these have been used to indicate disease 
severity[13-15] and to supplement full blood count (FBC) screening in the 
assessment of suspected infection, they are less widely available and 
are also affected by confounding factors. 
We recently described a practical procedure for quantitative fluorescent 
neutrophil CD64 (nCD64) measurements with a haematology 
analyser[16]. nCD64 corresponds to the high-affinity FcγRI receptor 
expressed by monocytes but not by normal neutrophils. Upregulated and 
detectable nCD64 is characteristically seen in patients with infection and 
its measurement is gaining acceptance as a useful marker in the 
assessment of sepsis[17-22]. Relatively little is known however about 
changes in nCD64 during the early stages of inflammation. To 
investigate this particular question, the present study examined the 
modulation of nCD64 expression during a standardized inflammatory 
stimulus using experimental human endotoxemia and compared this to 
changes in haematological and non-haematological (CRP, IFN-γ, TNF-α, 
IL-6 and IL10) parameters. Furthermore, the cytokine response during 
endotoxemia was correlated with CD64 expression to examine whether 
quantitative changes in CD64 expression reflect the magnitude of the 
innate immunity response. 
 
 
Materials and Methods 
Subjects: 
This study was approved by the local ethics committee and informed 
consent was obtained from each volunteer. Prior to the single-dose 
intravenous administration of 2 ng/kg E. coli O:113 LPS (US 
Pharmcopia, Rockvilee, MD, USA), ten healthy subjects (4 male, 6 
female; mean age 21 years, range 18-24 years) entered into the study 
were checked by routine medical examination, electrocardiography and 
blood analysis. With the exception of oral contraceptives, none of the 
 87
chapter 9 
volunteers used prescription medication, aspirin or other non-steroid anti-
inflammatory drugs and all were HIV and Hepatitis B negative. Medical 
appraisal confirmed that there was no history of a febrile illness in the 2 
weeks preceding the study, and in the 12 hour period prior to LPS 
administration all subjects refrained from caffeine, alcohol and food. In 
the post-LPS period, vital signs were continuously monitored and at 
various time intervals EDTA and heparin anticoagulated blood samples 
were taken for haematological, nCD64, CRP, interleukins and cytokines 
measurements. 
 
Analysis of Neutrophil CD64 (nCD64) Expression: 
nCD64 expression was measured at baseline and 1, 2, 4, 6, 12 and 22 
hours after LPS administration. As previously described[16], the 
immunofluorescent detection and quantification of nCD64 was performed 
using the Cell-Dyn CD4000 haematology analyser (Abbott Diagnostics, 
Santa Clara, CA, USA). In brief, non-anticoagulated vacutainer tubes 
containing 100 µL whole blood plus 20 µL anti-CD64 (FITC; Becton 
Dickinson) and 15 µL anti-Ia (PE; Becton Dickinson), were processed 
using the CD4000 automated CD4/CD8 assay mode after preliminary 
incubation at room temperature for 10 minutes. Raw data files were 
downloaded to a PC for population analysis.  Primary gating of the 
neutrophil population was facilitated with WINMDI software 
(http://facs.scripps.edu/software.html), using Ia expression to exclude 
monocytic components and optical characteristics (0o versus 7o) to 
exclude lymphocytes. This was followed by post-acquisition fluorescent 
channel compensation using WINList 4.0 software (Becton Dickinson). 
Statistical analyses of neutrophil FL1 histograms (3-decade log) were 
then undertaken to obtain median nCD64 staining intensities 
quantitatively expressed as Arbitrary Fluorescent Units (AFU). In a 
previous study the normal range for nCD64 was determined at a 
mean±SD of 94±14 AFU[16]. 
 
Haematological Studies:  
White blood cell (WBC) and absolute neutrophil counts (ANC) were 
measured at baseline and 1, 2, 4, 6, 12 and 22 hours after LPS 
administration using a Sysmex XE-2100 (Toa, Kobe, Japan) analyser. 
Immature granulocytes were enumerated with Sysmex instrument 
software (XE-master), while band cell counts were obtained by 
conventional microscopy (2x 200 cells) of May-Grünwald Giemsa stained 
blood smears. 
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Analysis of CRP, TNF-α, IFN-γ, IL-6 and IL-10: 
Serum CRP was measured at baseline and 1, 2, 4, 6, 12 and 22 hours 
after LPS administration using a turbidimetric method (Aeroset, Abbott 
Laboratories, Abbott Park, IL, USA).  Concentrations of tissue necrosis 
factor (TNF-α), γ-interferon (IFN-γ), and interleukins 6 (IL-6) and 10 (IL-
10) were determined at baseline and 1, 1½, 2, 3 and 4 hours after LPS 
administration using the simultaneous Luminex Assay (R&D Systems, 
Minneapolis MN, USA)[23]. 
 
Statistical Analysis:  
Descriptive results of continuous variables were expressed as mean ± 
standard error of the mean (SEM). Data analysis was performed using 
ANOVA with repeated measures. A p-value <0.05 was considered 
significant. Individual peak values of cytokines and interleukins were 
correlated (Pearson) with neutrophil CD64 expression at 22 hours after 
LPS administration. 
 
Results 
Subjects and Pre-LPS Baseline Analyses: 
Table 1 shows baseline values of the measured parameters. 
 
Post-LPS – Neutrophil CD64 (nCD64) Expression:   
The nCD64 expression following LPS administration shows a biphasic 
increment (figure 1). A first rise was seen after one hour with a maximum 
of 133±6 AFU after 2 hours (p=0.05), the second increment  started at 12 
hours with a maximum of 167±13 AFU at 22 hours (p=<0.0001). 
 
Post-LPS – Haematological Parameters:   
A rapid initial decline in the ANC following the intravenous administration 
of LPS was observed (figure 2 and table 1). At 1 hour, the mean ANC 
was 1.0±0.1x109/L compared to a pre-LPS value of 4.9±1.2x109/L 
(p<0.0001). Thereafter, the ANC showed a progressive increase to 
11.5±0.7x109/L at 6 hours and a subsequent declining trend to 
6.6±1.0x109/L at 22 hours (p<0.0001 for the whole curve). The immature 
granulocyte count showed a similar overall trend (p=0.03), although all 
values remained within the normal range (figure 2 and table 1). Band 
cells showed a clearer increase to maximal values 2 to 6 hours post-LPS 
(figure 2 and table 1). Mean band cell counts during this transient 
increase was 15±3%. Subsequent progressive declines to normal (<5%) 
band cell values were seen for all subjects at 22 hours (p<0.0001). 
Changes in ANC and band cell counts were not accompanied by any 
observable increase in neutrophil toxic granulation. 
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fig 1 
Time course trends of neutrophil CD64 (nCD64) following experimental LPS 
administration. 
 
 
Post-LPS – CRP, TNF-α, IFN-γ, IL-6 and IL-10: 
Serum CRP concentrations showed a relatively slow response compared 
to changes in haematological parameters and nCD64 expression. The 
mean CRP concentration at 6 hours was 6.9±0.6 mg/L, which then 
progressively increased over the post-LPS period to mean 
concentrations at 12 and 22 hours of 24.7±1.1 mg/L and 39.7±4.9 mg/L 
respectively (p<0.0001, figure 2 and table 1). 
For comparison, TNF-α and IFN-γ increased within one hour of LPS 
administration to mean peak values at 90 minutes of 1047±285 pg/mL 
and 170±42 pg/mL respectively (both p<0.0001, figure 3 and table 1). 
Decreases to relatively normal levels were seen within 4 hours post-LPS. 
For the interleukin markers, IL-6 increased within one hour to a mean 
peak value of 8338±4560 pg/mL at four hours (figure 3 and table1) 
(p=0.009), while IL-10 increased within one hour to a peak value of 
112±26 pg/mL at two hours (figure 3 and table 1) (p<0.0001). The 
nCD64 expression at 22 hours after LPS administration is associated 
with peak values of TNF-α (R2=0.76, p=0.002), IFN-γ (R2=0.78, p=0.002) 
and IL-6 (R2=0.81, p=0.001), whereas this correlation was not found for 
IL-10 (R2=0.05, p=0.54). Also, there was no significant correlation 
between nCD64 expression and CRP (R2=0.16, p=0.28). 
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fig 2  
Time course trends of sepsis 
parameters following 
experimental LPS administration; 
absolute neutrophil count (ANC, 
x109/L), absolute immature 
granulocyte count (IG, x109/L), 
microscopic band count (%) and 
C-reactive protein (CRP, mg/L) 
 
table 1 Comparison of all measured parameters at baseline level and time to 
reach maximum value 
 
parameter Reference 
value  
Mean baseline 
value±SEM 
Mean maximum 
value± SEM 
Time to mean 
maximum value 
(h) 
p-value 
ANC (x109/L) 2.0 - 6.5 4.9±1.2 11.6±1.2 6-12 <0.0001 
Band Cells (%) <5 <5±0 15±3 4-6 <0.0001 
IG (x109/L) 0.05 0.01±0 0.04±0.01 6-12 0.03 
CRP (mg/L) <5 7.2±2.4 41±5 22 0.0001 
IFN-γ  (pg/mL) nd 10.4±2.6 170±42 1.5 <0.0001 
TNF-α (pg/mL) nd 8±0 1047±285 1.5 <0.0001 
IL-10 (pg/mL) nd 8±0 112±26 2 <0.0001 
IL-6 (pg/mL) nd 11.7±2.7 8338±4560 4 0.009 
nCD64a (AFU) <145 108.8±7.5 133±6 
264±13 
1-2 
12-22 
0.047 
<0.0001 
a Neutrophil membrane CD64 expression expressed as 
Arbitrary Fluorescent Units (AFU). nd = not detectable 
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fig 3 
Time course trends of sepsis 
parameters following 
experimental LPS 
administration; tumour necrosis 
factor (TNF-α, pg/mL), 
interleukin-6 (IL-6, pg/mL), 
interleukin-10 (IL-10, pg/mL) 
and γ-interferon (IFN-γ, pg/mL)     
 
 
 
Discussion 
The present study demonstrates that in a standardized inflammation 
model nCD64 expression shows a biphasic response. The first phase of 
this response coincides with the increment of cytokines, whereas the 
second phase shows the same trend as the CRP. The nCD64 
expression at 22 hours after LPS administration is associated with peak 
values of pro-inflammatory cytokines, whereas this correlation was not 
found for IL-10 and CRP, suggesting that the nCD64 expression is a 
quantitative marker of the innate immune response. Furthermore, this 
study confirms that nCD64 can be rapidly and easily measured using a 
routine haematology analyser. 
 
Upregulation and increased expression of nCD64 appears to be a 
sensitive marker for early-onset clinical infection in newborn children[22, 
24]. In adults its use has been variably suggested for differentiating 
systemic infection from active inflammatory disease[25], monitoring γ-
interferon therapy[18] and as an indicator for initiating or discontinuing 
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antibiotic treatment[22]. nCD64 analysis may also be useful for assessing 
sepsis while haematological parameters such as leukocyte/granulocyte 
counts, or the presence of immature granulocytes and band cells are 
relatively uninformative[26, 27]. Especially in young children and elderly 
patients, disorders with primary disturbances in neutrophil numbers, and 
conditions where neutrophil counts are affected by myelosuppressive 
therapies, nCD64 analysis might be helpful. Our observation that nCD64 
expression correlates with a rise in pro-inflammatory cytokines 20 hours 
earlier further substantiates the notion that nCD64 expression is a 
quantitative measure of the innate immune response (table 2). 
 
table 2 Correlation between CD64, 22 hours after LPS administration and other 
sepsis parameters at their peak value 
parameter R2 p-value 
CRP 0.1666 0.2755 
IFN-γ 0.7812 0.0016 
TNF-α 0.7614 0.0021 
IL-10 0.0548 0.5444 
IL-6 0.8091 0.0010 
 
The potential value of nCD64 measurements in patients with suspected 
sepsis has been described previously. A sensitivity of 94.1% and a 
specificity of 84.9%, and positive predictive likelihood ratio of 6.24 have 
been reported[28]. Relatively little is known about the changes in the 
expression of this receptor during the initial stages of infection in 
humans. In order to investigate this particular point, we used an 
accepted model for Gram-negative sepsis (experimental human 
endotoxemia) and examined the resulting trends of nCD64 expression 
and compared these with a number of other parameters (i.e. CRP, ANC, 
IG, band cells, IFN-γ, TNF-α, IL-6, and IL-10) used for monitoring 
inflammatory processes. Human LPS exposure has been used 
previously by other investigators as an experimental model to examine 
diverse aspects of the inflammatory response including vascular 
permeability[29], neuropsychological functions[30], pharmacomodulation[31, 
32], and changes in leukocyte antigen expression[33-35]. 
In this study, we show that changes in nCD64 expression following LPS 
administration can generally be characterized as biphasic. There was an 
initial increased expression within 1-2 hours while a second, more 
significant incremental nCD64 response, starting at 6 hours and reaching 
maximum levels at 12-22 hours, was seen in all subjects. The mean 
peak values for these two phases were 120 and 165 AFU, respectively, 
compared to a mean baseline level of 102 AFU and a previously defined 
upper normal limit of 109 AFU. In our experimental LPS model, nCD64 
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increments were above the upper normal limit, but less pronounced 
compared to septic patients[16]. 
This almost certainly reflects the relatively mild and limited exposure to 
endotoxin in an experimental setting compared to clinically important 
sepsis where endotoxin exposure is more prolonged and typically of 
greater magnitude. 
 
In examining relationships between haematological changes and nCD64 
expression, we found that LPS administration was accompanied by an 
initial rapid decline in the absolute neutrophil (ANC) and immature 
granulocyte (IG) counts at 1 hour, followed by an increase that reached a 
maximum at 6 hours and then a decline to relative normality at 22 hours.  
The possibility that the initial ANC decline was a result of increased 
sequestration (extravasculation), with the subsequent increase resulting 
from an expanded release of marrow neutrophils, is supported to some 
extent by the observation of transiently increased proportions of band 
cells between two and six hours post-LPS. Moreover, the automated IG 
count showed also a small but significant increase in the same period 
although values remained within the normal range. We hypothesize that 
the initial small increase in nCD64 expression that was seen and the 
more consistency observed decline in the ANC might be due to a direct 
modulating effect of LPS on circulating mature neutrophils. For the 
second and more sustained increase in nCD64 expression however, 
which was paralleled by a rising ANC, we postulate that newly released 
neutrophils from marrow/storage pools may have constitutively 
upregulated nCD64 levels. 
 
Analysis of the biochemical and immunological markers revealed 
relatively little change in CRP levels in the first six hours post-LPS, 
although a consistent and significant progressive increase was seen 
thereafter. In contrast, TNF-α, IFN-γ and IL-10 increased significantly 
within one hour and IL-6 within 2 hours. These findings are in agreement 
with previous studies[29].  
While interpreting the results of this study, it is important to note that the 
LPS administration comprised a single dose and that any subsequent 
effects would essentially be short-lived as the stimulus is progressively 
reduced by the host response (LPS clearance). Nevertheless, while a 
single dose exposure cannot be extrapolated to clinical situations where 
stimulation by a mediating agent such as LPS is likely to be more 
prolonged, our study provide valuable insights into the relative rates and 
magnitudes of early cellular and biochemical changes. By this means, 
we found that changes in nCD64 expression proceeded CRP but lagged 
behind increases in TNF-α, IFN-γ, band cells, IL-6 and IL-10. With 
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regards to laboratory and clinical application, the cytokine and interleukin 
assays are unlikely to be available in many routine laboratories while the 
more widely available band cell estimates and CRP measurements both 
suffer from low diagnostic specificity[36]. 
In conclusion, compared to other haematological indices nCD64 
expression shows a biphasic response to LPS administration. A 
correlation of nCD64 is found with TNF-α, IFN-γ and IL-6, but not with IL-
10 and CRP (table 2). Measurements of interleukins and cytokines takes 
some time thereby hampering the availability of these markers in sepsis 
diagnosis. Therefore nCD64 might be a potential sepsis marker, which 
can be measured on a routine haematology analyser. 
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Abstract 
A patient with abdominal sepsis had both intra and extracellular bacteria 
in a blood smear and high levels of neutrophil membrane CD64 and 
HLA-Dr. Intracellular bacteria are only observed in the terminal phase of 
a sepsis. Our patient recovered, suggesting that a high expression of 
neutrophil CD64 is indicative for a good prognosis. 
 
 
Case report and methods 
A 3-year-old boy treated for acute lymphoblastic leukaemia, developed a 
perforation of the distal oesophagus during chemotherapy. He developed 
severe oesophageal stenosis and a tracheo-oesophageal fistula.  
Associated feeding difficulties and recurrent lower respiratory tract 
infections required surgical correction by oesophagectomy and insertion 
of a gastric tube. Seven days later he developed severe pancolitis, which 
was treated with total parenteral feeding and metronidazole. On day 14, 
while in intensive care, he developed septic shock and respiratory 
insufficiency. Haematological investigations revealed anaemia (Hb 4.9 
mmol/L) with normal platelet (347 x109/L) and white blood cell (9.9 
x109/L) counts. The leukocyte differential comprised 5% 
metamyelocytes, 20% non-segmented (band) neutrophils, 58% 
segmented neutrophils, 13% lymphocytes and 4% monocytes. Intra-
neutrophilic and extracellular bacteria as well as neutrophil toxic changes 
(figure 1) were also noted. 
 
fig 1 
(a) Peripheral blood neutrophils showing both intra-neutrophilic and extracellular 
bacteria(arrows). (b) Neutrophil with internalised bacteria (arrow) and toxic changes 
(hypergranularity and vacuolation).  
 
Other laboratory findings included a C-reactive protein of 229 mg/L 
(normal <5 mg/L), fibrinogen 5,910 mg/L (normal 1,500-3,500 mg/L) and 
D-dimer 15,970 ng/mL (normal <500 ng/mL). A diagnosis of bacterial 
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septicaemia with secondary disseminated intravascular coagulation 
(DIC) was made and broad-spectrum antibiotics (meropenem and 
tobramycin) were started after collection of blood, urine and tracheal 
secretions for culture. He was intubated because of respiratory failure 
and the port-a-cath was removed as it was considered the likely source 
of the bacteraemia. A laparotomy was also performed because of 
suspected intestinal perforation and large amounts of ascites were 
removed. The small intestines were vital with no abnormalities, and the 
colon showed signs of pancolitis without a perforation. The abdomen 
was left open to ensure efficient drainage. Blood cultures from the port-a-
cath and from peripheral veins revealed Enterobacter aerogenes and 
Enterococcus faecalis. The following day, renal failure and liver function 
abnormalities developed together with persistent lactic acidosis, 
hyperglycaemia and hypertension. High ventilation pressures were 
required to induce adequate oxygenation. Further haematological 
investigations showed a slight increase in the granulocyte count (to 9.0 x 
109/L) and moderate thrombocytopenia (97 x 109/L). Four days after 
laparotomy, his clinical condition improved and enteral feeding by 
jejunostomy was started. Renal and liver function improved, CRP 
decreased to normal levels, platelet count and DIC recovered, and the 
fever disappeared. Extubation followed after 7 days of artificially 
ventilation. He was treated for 2 weeks with meropenem and teicoplanin. 
Three weeks later, a Ramirez abdominoplasty was performed and a 
perforation of the colon found and attributed as the focus of his poly-
microbial septicaemia. At present, the boy is doing relatively well. 
In addition to standard laboratory investigations, an analysis of neutrophil 
membrane CD64 and HLA-Dr (Ia) expression was undertaken in a blood 
sample taken at the initial sepsis work-up at the moment of clinical 
presentation of bacteraemia. Measurement of neutrophil membrane 
CD64 (PMN-CD64) has been the subject of recent reports[1, 2] and is 
considered potentially useful for the diagnostic assessment of sepsis for 
patients when conventional haematological parameters may be 
uninformative[3]. The CD64 antigen is a high-affinity receptor (FcγRI) 
expressed by monocytes but not by normal neutrophils. However, 
upregulated and detectable expression of PMN-CD64 is mediated by 
lipopolysaccharides, γ-interferon and granulocyte colony-forming factor 
(G-CSF)[4], and is also characteristically seen in patients with infection. In 
contrast, constitutively expressed membrane Ia by immature 
granulocytes is effectively lost with neutrophil differentiation from the 
myelocyte. 
The immunofluorescent detection and quantitation of neutrophil CD64 
and Ia was performed using the Cell-Dyn CD4000 haematology analyser 
(Abbott Diagnostics, Santa Clara, CA, USA) as previously described[5]. 
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Patient expression of neutrophil CD64 and Ia was compared to a series 
of 10 healthy individuals (4 males, 6 females; mean age 21, range 18-24 
years, without febrile illness or medication in the 2 weeks preceding the 
study). These studies revealed that granulocytes in our patient had a 
markedly increased median expression of CD64 of 750 AFU (Arbitrary 
Fluorescent Units) compared to a normal median of 98 AFU (SD 8.7) 
(figure 2). Expression of membrane Ia (figure 2) was also significantly 
increased (26.4 AFU) compared to normal (median 10.7, SD 0.6) 
although this level of expression is relatively low compared to monocyte 
expression, which is typically in excess of 260 AFU[5]. 
 
fig 2 
Quantitative staining intensities for 
neutrophil membrane CD64 and HLA-Dr 
(Ia) expression. Neutrophils were gated 
according to optical scatter characteristics 
(0º versus 7º), and post-acquisition 
fluorescent channel compensation was 
then applied. The histogram displays of 
FL1 (CD64) or FL2 (Ia) staining for our 
patient (shaded) are compared to those 
obtained from 10 normal control samples. 
Neutrophil CD64 staining profiles were 
normally distributed while Ia expression 
was typically non-normal. Note the 
markedly increased CD64 and the weakly 
increased Ia expression. The minor 
population of granulocytes in our patient 
(arrow) with higher Ia staining may 
correspond to the small proportion of 
immature granulocytes (metamyelocytes) 
noted in the morphological differential.  
 
 
 
Discussion 
The expression of neutrophil CD64 was very high in our patient at the 
time of clinical presentation with bacteraemia. In a previous study of 117 
patients, comprising patients with and without known infections, using 
the same assay procedure[5], only six were found with a neutrophil CD64 
level exceeding 700 AFU, with the mean CRP values for these being 260 
mg/L (range 176-360 mg/L), indicating that a high CRP value is 
associated with a high CD64 level. Determination of neutrophil 
membrane Ia expression has not been systematically looked at 
previously although one report found that increased Ia expression could 
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be induced in some patients treated with γ-interferon[6]. We took the 
opportunity to analyse this in our patient and found a modest but 
nevertheless significant increase compared to normal. To establish 
whether this could be a consistent phenomenon, neutrophil Ia expression 
was retrospectively determined for the six previously investigated 
samples with high neutrophil CD64. The mean neutrophil Ia level for 
these was 21.7 AFU (observed 18.4 – 25.4 AFU) and thus similar in 
magnitude to that seen with our patient. While these higher values could 
reflect the presence of immature components, as our patient indeed had 
a leukocyte differential that included 5% metamyelocytes and 20% band 
cells, this is considered unlikely as only three of these six patient 
samples did show immature granulocytes[5]. Disordered granulopoiesis, 
such as cellular asynchrony, might also be proposed as a reason for high 
neutrophil CD64 expression in patients with leukaemia although again 
unlikely as the primary malignancy in our patient was lymphoid in nature 
and at the time of this episode of bacteraemia the leukaemia was in 
remission.  
 
Excluding samples with post-venesection contamination, intracellular 
bacteria are only observed in blood smears in the terminal phase of 
sepsis[7-9].  Earlier reports suggest that neutrophil CD64 expression can 
be used for diagnostic assessment of sepsis[2, 10], and that a poor 
prognosis is associated with a lower neutrophil CD64 (and monocyte Ia) 
expression[11, 12]. 
With regards to monocyte Ia, significant reductions are characteristically 
seen in patients with sepsis[11, 13, 14] with reversion to normal levels of 
expression as sepsis-associated transient immunosuppression is 
overcome[15]. However, this measurement can be problematic in patients 
when severe monocytopenia occurs during the acute stages of sepsis.  
Analysis of neutrophils in such circumstances thus offers a number of 
advantages. We therefore evaluated a new and simple approach for 
measuring these cellular antigens with a routine haematology analyzer 
and confirmed markedly elevated CD64 expression in our patient, and 
additional evidence for mildly upregulated membrane Ia. While the 
diagnosis in our patient was not in doubt, these observations 
nevertheless suggest that such measurements could be useful in 
investigating patients where a suspicion of sepsis is more equivocal.  
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Summary 
 
In this thesis we describe controversial morphologic features in both 
microscopic and automated differentiation of blood cells. In addition, we 
have investigated alternative methods to overcome these shortcomings. 
Furthermore we describe the variance of microscopic counting of band 
cells and variant lymphocytes. We also describe the automated 
measurement of platelets in acute leukaemias. Finally, we describe 
alternatives for sepsis diagnosis. 
 
In Chapter 2 we describe the presence of bacteria in blood smears 
observed by microscopy. These bacteria were not yet defined using 
standard microbiological methods. This early detection of bacteria may 
have major therapeutic consequences. Presence of bacteria in blood 
smears from asplenic patients, especially Capnocytophaga canimorsus, 
may have a dramatic outcome, which may have major therapeutic 
consequences. Therefore it is important to investigate their origin of 
presence. These bacteria may be a result of a fulminant sepsis, catheter 
related infection, or contamination. Intra- and/or extra cellular bacteria 
are frequently found in patients with a central venous catheter (CVC), 
and may point to a catheter related infection. Since blood samples of 
these patients are obtained by the CVC, blood sampling by finger 
puncture may exclude a catheter related infection. If in these samples no 
bacteria are found the CVC should be removed since removal leads to 
recovery of the infection. Bacteria as result of contamination may appear 
both intra- and extracellular. If additionally undefined coloured pieces are 
seen in the blood smear, filled with similar bacteria, these are likely to be 
due to in vitro contamination. 
 
Automated analysers may generate flaggings in case of suspicious 
abnormal cells. In Chapter 3 we describe the overestimation of atypical 
lymphocytes or left shift in case of flagging for these cells. Five slides 
with a various amount of atypical lymphocytes and five slides with 
different amount of band cells were observed by 30 technicians of three 
laboratories. No supplemental information was given. After a period of 
two months the same slides were observed by the same technicians, but 
now accompanied by supplemental haematological information. Flagging 
for atypical lymphocytes resulted in an overestimation of atypical 
lymphocytes, whereas in flagging for left shift no overestimation was 
achieved. This may be due to the enormous intervariation of band cell 
counting. 
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In Chapter 4 we describe this variation of band cell enumeration. This 
was tested among Dutch hospital laboratories. Blood of a septic patient 
was used to obtain a blood smear. At random 100 white blood cells were 
micro photographed. These images were processed in a PowerPoint 
presentation. The PowerPoint presentation was sent out to 157 
laboratories with the request to differentiate the cells. Eighty-six percent 
of the laboratories responded (756 individuals) and the results were 
compared. For band cells a SD was found of 11.0% in a range of 4-64%. 
Segmented neutrophils revealed a SD of 11.0% in a range of 15-72%. 
One year later a second PowerPoint presentation of the same patient 
was sent. This time we requested to differentiate cells but not to 
differentiate between band cells and segmented neutrophils. Seventy-
three percent of the laboratories responded (637 individuals) and 
resulted in a SD of 2.0% for the neutrophils with a range of 59-77%.  
 
Abnormal lymphocytes may appear in different diseases as well as an 
artefact. In chapter 5 the divergent assessment of atypical lymphocytes 
is described. An abnormal morphology of lymphocytes may be 
suggestive for infection or a (premalignant) neoplasm. However, 
morphology of lymphocytes is difficult to interpret. Of a patient with a mild 
lymphocytosis (56% lymphocytes), which was normal for the patients 
age, 100 at random cells were micro photographed and processed in a 
PowerPoint presentation. This PowerPoint presentation was sent to 157 
Dutch hospital laboratories. They were requested to differentiate the 
blood cells. Moreover, the participants were asked to differentiate 
lymphocytes in normal, atypical, plasma cells, prolymphocytes or 
(lympho)blasts. The response was 73% (671 individuals). For only 7 cells 
(normal lymphocytes) a concordance of >90% was reached, which mean 
that more than 90% of the observers called these cells a normal 
lymphocyte. With respect to the other 49 cells there was no concordance 
at all. Classification resulted in various types of lymphocytes. One cell 
was shown twice in the PowerPoint presentation. Twohundred-ten out of 
671 persons classified this same cell as two different subtypes. 
Nevertheless, reporting atypical lymphocytes may contribute to a rapid 
diagnosis of storage diseases, which is described in Chapter 6. 
Automated flagging for atypical lymphocytes lead to a microscopic 
observation of the blood smear. In this smear abnormal lymphocytes 
were observed. These lymphocytes differed from reactive or neoplastic 
lymphocytes. Vacuole like inclusion bodies were seen and were 
suggestive for a rare autosomal storage disease, the so-called I-cell 
disease. The diagnosis was confirmed by electron microscopy and 
lysosomal enzyme levels in fibroblasts and serum. 
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In the past, microscopic assessment of platelet morphology was used. 
However, nowadays it is not used since it is labour intensive and 
imprecise. Microscopic observation of platelet morphology however, may 
be useful in cases where spurious thrombocytosis can be expected. In 
Chapter 7 we describe the incidence of spurious platelet counts in acute 
leukaemias. In acute leukaemia, platelet-sized particles may be present 
in the blood. In a retrospective study of 169 patients, pseudoplatelets 
were found in 43 patients. Seven patients were even re-classified as 
having a major bleeding risk, which means they have a true platelet 
count of less than 15x109/L. 
 
Sepsis can lead to septic shock and death. The incidence of sepsis is 
about 95 cases per 100,000 patients in the United States of America. 
Because mortality increases with progressive sepsis, early detection of 
sepsis is very important. Haematological, biochemical and immunological 
analyses are variously used as sepsis parameters. Expression of CD64 
(high affinity FcγRI receptor) on neutrophils (nCD64) has been the 
subject of recent research. In Chapter 8 a new method is described to 
measure neutrophil nCD64 and HLA-DR in an easy way on a routine 
haematology analyser. The Cell Dyn 4000 (Abbott Diagnostics) can be 
expanded with a special module to measure the monoclonals CD4 and 
CD8. Using this module nCD64 and HLA-DR can be analysed. Multiple 
plot files can be generated with parameter options being 7º intermediate 
angle scatter, 0º Axial Light Loss (size), FL1, FL2 and FL3. Measurement 
of neutrophil CD64 and monocyte HLA-DR as described in this chapter 
overcomes a number of limitations of flow cytometry. The use of nCD64 
is described in Chapter 9. During experimental human endotoxemia the 
modulation of nCD64 expression is examined and compared with other 
sepsis parameters such as haematological indices, CRP, cytokines and 
interleukins. 
In Chapter 10 a patient is described suffering from abdominal sepsis with 
both intra and extracellular bacteria in the blood smear. This patient had 
high levels of nCD64 as well as high levels of HLA-DR expression on 
neutrophils. Normally, intracellular bacteria are only observed in the 
terminal phase of sepsis. Since the described patient recovered, we 
hypothesize that a high nCD64 expression might be indicative for a good 
prognosis. 
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Conclusions and prospectives 
 
Microscopic differentiation of blood cells is a time consuming and 
inaccurate laboratory test, which requires expertise and experience. The 
inaccuracy is due to the small amount of cells, which is counted. 
Automated differentiation saves a lot of time and the obtained results are 
statistically more reliable. However, the flagging for abnormalities, shows 
less specificity and leads to overestimation of abnormalities. The 
technician usually does not have any clinical indication for a differential. 
This may result in unnecessary information for the clinician, e.g. 
presence of atypical lymphocytes in patients with a diagnosed viral 
infection does not provide essential information. Therefore most of the 
microscopic observations are superfluous and the differentials must be 
reduced. 
Automated flagging for band cells (left shift) should not be evaluated by 
microscopic observation. Because of the enormous variation in 
quantification of band cells, and the huge intra- and intervariation, 
reporting of absolute neutrophil count is sufficient. Additional laboratory 
parameters such as C-reactive protein (CRP) and procalcitonin (PCT) 
provide more information in addition to the absolute neutrophil count. 
Interleukins and cytokines may provide additional specific information.   
Neutrophil CD64 expression is a promising cellular sepsis marker, which 
can be measured using a haematology analyser (Cell Dyn 4000). 
Moreover, a high expression of neutrophil CD64 might be suggestive for 
a good prognosis in bacteraemia. 
In this thesis we also show that morphology of atypical lymphocytes  
without any clinical information leads to confusion while morphology is 
indistinct. Therefore, morphologic evaluation of lymphocytes should only 
be performed when accompanying clinical information is present. 
 
The development of new haematology instruments with expandable 
possibilities, e.g. analysis using monoclonals like neutrophil CD64, will 
lead to a further decrease in microscopic blood cell morphology. In 
addition, the development of automated cell recognition systems will 
make manual microscopy redundant. Both developments will lead to a 
reduction of the microscopic blood cell differentiation in the future. 
Therefore, in laboratories, a small group of experts should be formed and 
well trained by means of educational programmes and national quality 
assessments. 
 
Although controversies in microscopic examination of blood cells are 
profound, in some cases it is still required. In 2000 the Dutch Association 
of Laboratory Haematology Diagnosis (Vereniging Hematologische 
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Laboratoriumdiagnostiek; VHL) presented recommendations concerning 
the use of microscopic differentiation of blood cells. In their conclusions, 
which are mainly based on stat indications, reduction of microscopic 
differentiation of white blood cells should be established. We recommend 
to perform a microscopic white blood cell differentiation, whether 
emergency or not, in the next cases: 
• In acute leukaemia in order to exclude pseudothrombocytosis 
• If inexplicable diseases are present which can not be explained by 
other laboratory diagnosis 
• If haematology analysers show ambiguous interpretable 
scatterplots 
• In case of possible pseudothrombopenia 
When microscopic examination of white blood cells is necessary 
(indicated) a screening for abnormalities is sufficient. In that case 
microscopic white blood cell differentiation is not necessary at all. 
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Bloedcellen 
In één liter bloed bevinden zich ongeveer 4x1012 rode bloedcellen 
(erytrocyten), die verantwoordelijk zijn voor het zuurstoftransport. Als er 
te weinig voedingsstoffen (zoals ijzer) worden ingenomen heeft dat 
gevolgen voor de aanmaak van deze rode bloedcellen. Men spreekt dan 
van bloedarmoede (anemie). In het laboratorium kan anemie worden 
vastgesteld. 
 
rode bloedcellen 
 
Daarnaast bevat het bloed witte bloedcellen (leukocyten), die zorgen 
voor de afweer tegen onder andere bacteriën en virussen. Eén Liter 
bloed bevat ongeveer 10x109 witte bloedcellen. Maar ook op ander 
plaatsen in het lichaam komen witte bloedcellen voor. De witte 
bloedcellen zijn divers met verschillende functies. De granulocyten 
zorgen voor de bacteriële afweer, terwijl de lymfocyten voor de virale 
afweer (bv een verkoudheid) zorgen. Een eosinofiele granulocyt is vooral 
zichtbaar bij hooikoorts en andere allergieën. 
De verschillende witte bloedcellen 
 
lymfocyt granulocyt eosinofiele 
granulocyt 
 
Tenslotte bevat het bloed ook bloedplaatjes (trombocyten). Deze kleine 
cellen zijn noodzakelijk voor de bloedstolling. Bij het ontstaan van een 
wond plakken bloedplaatjes aan elkaar (aggregeren) aan de wondrand. 
Deze aggregaatvorming stimuleert de bloedstolling. Er circuleren 
ongeveer 150x109 bloedplaatjes in één liter bloed. 
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bloedplaatjes 
 
De bloedcellen (gemiddelde grootte is 0,007 mm) kunnen onder een 
microscoop bekeken worden. Hiervoor wordt een druppel bloed 
uitgestreken op een glaasje waardoor een heel dunne bloedfilm ontstaat. 
Bij ziekte kan de hoeveelheid bloedcellen of de verdeling van de 
bloedcellen verstoord zijn. Daarom worden deze tellingen vaak 
uitgevoerd in laboratoria. 
 
Automatische celtellers 
Naast de microscoop kunnen ook automatische celtellers gebruikt 
worden. Cellen worden al sinds decennia geteld op automatische 
bloedceltellers en tegenwoordig zijn de celtellers in staat de 
verschillende soorten cellen te herkennen (differentiatie). De kwaliteit 
van deze celtellers is dusdanig dat ze nauwkeurigere resultaten geven 
dan analyses met behulp van de microscoop. Bovendien is de 
apparatuur zo gevoelig dat deze vaak een signaal geeft voor een 
abnormaliteit zonder dat er sprake is van een afwijking. Het komt echter 
ook voor dat bepaalde afwijkingen niet gezien worden. 
 
In hoofdstuk 2 worden 4 cases besproken waarbij bacteriën in het bloed 
aanwezig zijn. Dit kan duiden op een ernstige bloedvergiftiging (sepsis), 
of het gevolg zijn van een katheter gerelateerde ontsteking. Echter, deze 
bacteriën kunnen ook het gevolg zijn van vervuiling na het prikken. 
Omdat aanwezigheid van bacteriën een ernstige zaak is, is het belangrijk 
om te weten of er sprake is van sepsis, ontsteking of verontreiniging. 
Automatische celtellers herkennen geen bacteriën in het bloed. Echter, 
meestal gaat een ernstige sepsis gepaard met andere afwijkingen 
waarvoor de automatische celteller wel een alarm geeft. Indien bacteriën 
gevonden worden in een bloeduitstrijkje is het dus altijd belangrijk eerst 
te onderzoeken of er sprake is van verontreiniging of sepsis.  
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bacteriëmie 
 
De automatische bloedceltellers kunnen aangeven of er een verdenking 
is van aanwezigheid van afwijkende cellen. Het kan ook leiden tot een 
onjuiste inschatting van een afwijking omdat de beoordelaar met de 
informatie van de automatische celteller eerder geneigd is de gemelde 
afwijking te zien. In hoofdstuk 3 wordt beschreven dat alarmering voor 
atypische lymfocyten (abnormale lymfocyten) door de automaat leidt tot 
overschatting van atypische lymfocyten in een bloeduitstrijkje. 
Alarmering voor een zogenaamde linksverschuiving (aanwezigheid van 
jonge granulocyten) leidt daarentegen niet tot overschatting. Bij dit 
onderzoek zijn 5 gekleurde bloeduitstrijkjes, met wisselende hoeveelheid 
atypische lymfocyten, door 30 analisten uit 3 ziekenhuizen beoordeeld. 
Ook zijn 5 gekleurde bloeduitstrijkjes met wisselende hoeveelheid 
staafkernige granulocyten meegestuurd. Er werden geen 
hematologieuitslagen vermeld. Na 2 maanden werden dezelfde 
uitstrijkjes nog eens ter beoordeling aangeboden. Nu gingen de 
uitstrijkjes vergezeld van informatie zoals alarmering voor atypische 
lymfocyten en/of aanwezigheid van jonge granulocyten. De resultaten 
wezen uit dat alarmering voor atypische lymfocyten leidt tot een 
overschatting van het aantal atypische lymfocyten. Vreemd genoeg is 
dat niet het geval voor staafkernige granulocyten. Dat wordt 
waarschijnlijk veroorzaakt door de grote variantie in het tellen van 
staafkernige granulocyten. 
In hoofdstuk 4 is deze bevinding verder uitgewerkt. Van het 
bloeduitstrijkje van een patiënt met een sepsis (bloedvergiftiging waarbij 
jonge granulocyten in het bloed verschijnen) zijn 100 microfoto’s 
gemaakt en in een PowerPointpresentatie gezet. Deze presentatie is op 
cd-rom gezet en verstuurd naar 157 ziekenhuislaboratoria met het 
verzoek om de cellen te differentiëren. 106 Laboratoria stuurden hun 
resultaten in met 756 individuele beoordelingen. Zowel het 
laboratoriumgemiddelde als het individuele gemiddelde werd verwerkt. 
Het gemiddeld gevonden aantal staafkernige granulocyten was 31% met 
een spreiding van 4-64%! Voor de segmentkernige granulocyten werd 
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een gemiddelde gevonden van 44% met een spreiding van 15-72%. Van 
dezelfde patiënt werd na 1 jaar een nieuwe set beelden gemaakt en naar 
dezelfde laboratoria gestuurd. Echter, deze keer werd verzocht om geen 
onderscheid te maken tussen staafkernige en segmentkernige 
granulocyten. Van de 157 laboratoria werden door 114 laboratoria 
resultaten ingestuurd met een totaal van 637 individuele resultaten. Het 
gemiddelde aantal granulocyten bedroeg 70% met een spreiding van 59-
77%. Dat men moeite heeft om van de staaf afscheid te nemen bleek uit 
het feit dat op veel formulieren toch werd aangegeven hoeveel 
staafkernige granulocyten aanwezig waren. Gezien de geringe klinische 
betekenis van de staafkernige granulocyt en de enorme spreiding wordt 
aanbevolen om geen staafkernige granulocyten meer te rapporteren. 
 
staafkernige granulocyt 
 
De morfologie van lymfocyten kan bijdragen tot een snelle diagnose van 
een kwaadaardige ziekte of een infectie met een virus. Soms kan ook 
een zeldzame afwijkingen gediagnosticeerd worden. Echter, de 
beoordeling van afwijkende lymfocyten is nogal divers. In hoofdstuk 5 is 
de diversiteit in het beoordelen van lymfocyten onderzocht. Van het 
bloed van een patiënt met veel lymfocyten werd een uitstrijkje gemaakt 
en gekleurd. 100 beelden werden gefotografeerd en in een 
PowerPointpresentatie gezet. Dit werd aan 157 laboratoria gestuurd met 
de vraag of een differentiatie uitgevoerd kon worden, waarbij bovendien 
aandacht voor lymfocyten werd gevraagd. Lymfocyten dienden 
onderscheiden te worden in normaal, atypisch, jong, plasmacel of blast. 
Er was een respons van 73% met een totaal van 671 individuele 
resultaten. Het gemiddelde aantal lymfocyten bedroeg 56%. Van deze 
56% werden slechts 7 cellen door meer dan 90% van de personen als 
normaal beoordeeld. Voor 49 cellen werden verschillende beoordelingen 
gevonden: 30 cellen kregen twee verschillende beoordelingen, 11 cellen 
drie, voor 7 cellen 4 en voor 1 cel zelfs 5.  Eén cel kwam 2 keer voor in 
de presentatie. Maar liefst 210 personen (van de 671) beoordeelden de 
cel verschillend! Dit maakt het probleem van de beoordeling van 
lymfocyten duidelijk. Zonder extra informatie (anamnese, vraagstelling) 
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kan het beoordelen van lymfocyten tot verwarring en dus vertraging van 
de diagnose leiden. Dat het vaststellen van afwijkende lymfocyten wel 
degelijk belangrijk is, blijkt uit de casus die beschreven is in hoofdstuk 6. 
Een zeldzame overerfbare stapelingsziekte werd eerder ontdekt dankzij 
de beschrijving van afwijkende lymfocyten. Dit leidde tot 
vervolgonderzoek waaronder electronenmicroscopie en meting van 
lysosomale enzymen. Aan de hand van deze resultaten werd de 
diagnose definitief gesteld. 
 
Atypische lymfocyt 
 
Bloedplaatjes (trombocyten) worden tegenwoordig altijd automatisch 
geteld. Microscopische telling van bloedplaatjes met behulp van een 
telkamer gebeurt slechts zelden. In hoofdstuk 7 wordt de 
bloedplaatjestelling bij acute leukemie onderzocht. Acute leukemie is een 
kankersoort waarbij de bloedcellen woekeren. De primaire bron van deze 
kankervorm is in het beenmerg. De vorming van bloedcellen speelt zich 
af in beenmerg en het lymfatisch stelsel. Als in het beenmerg cellen 
ongecontroleerd gaan delen worden, in plaats van rijpe cellen, jonge 
bloedcellen in het bloed afgegeven. Deze jonge cellen hebben in het 
bloed geen functie en verdringen de normale cellen. Daardoor ontstaat 
een tekort aan rijpe bloedcellen. Hierdoor komen zuurstoftransport, 
afweer en bloedstolling in gevaar. Het tekort aan bloedplaatjes leidt tot 
langdurige bloedingen. Het aantal bloedplaatjes kan zo ver dalen dat een 
transfusie met bloedplaatjes gegeven moet worden. Kankercellen in het 
bloed kunnen cytoplasmafragmenten afsplitsen. Deze kunnen net zo 
groot zijn als bloedplaatjes. Omdat een hematologieautomaat het 
verschil niet ziet tussen bloedplaatjes en deze celfragmenten 
(pseudoplaatjes) zal het aantal automatisch getelde bloedplaatjes hoger 
zijn dan het in werkelijkheid is. Bij 169 patiënten met een acute leukemie 
is microscopisch onderscheid gemaakt tussen echte bloedplaatjes en 
pseudoplaatjes. Bij 43 patiënten zijn pseudoplaatjes gevonden en bij 7 
patiënten leidde dat zelfs tot een herclassificatie van het bloedingsrisico. 
Hierbij is aangetoond dat het belangrijk is om de morfologie van 
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bloedplaatjes bij patiënten met een acute leukemie microscopisch te 
beoordelen om te kijken of het aantal getelde bloedplaatjes wel klopt. 
 
pseudoplaatjes en trombocyten 
 
Sepsis kan ontstaan als gevolg van infectie en kan leiden tot een 
septische shock. Dit is een levensbedreigende complicatie. Daarom is 
het belangrijk de symptomen van sepsis in een vroeg stadium te 
onderkennen. Soms kan dat aan de hand van een bloeduitstrijkje waar 
bacteriën gezien worden (hoofdstuk 2). Het is dan eigenlijk al te laat. Er 
zijn tal van chemische stoffen en cellen bij een sepsis betrokken. Aan- of 
afwezigheid daarvan kan tot een juiste diagnose leiden. Er is echter 
(nog) geen ideale sepsismerkstof. De meeste merkstoffen zijn niet 
specifiek en kunnen ook bij andere aandoeningen voorkomen. Daarbij 
komt ook dat infectie en/of sepsis een zeer ingewikkeld proces is waar 
een hele reeks stappen bij betrokken is. Het begint met het herkennen 
van een ziekteverwekkend element (pathogeen) en via een lange keten 
van gebeurtenissen zal de gastheer hierop reageren. Herkenning van 
deze zogenaamde microbe-geassocieerde molecuulpatronen gebeurt 
door receptoren op cellen en hebben tot gevolg dat allerlei cytokines 
worden geproduceerd. Cytokines zijn eiwitten die de communicatie 
tussen afweercellen en andere cellen verzorgen tijdens 
ontstekingsreacties. Als gevolg van sepsis migreren geactiveerde witte 
bloedcellen vanuit het weefsel naar de ontstekingshaard. Het beenmerg 
maakt nieuwe cellen aan waardoor jonge onrijpe cellen in het bloed 
verschijnen. Dit zijn onder andere de staafkernige granulocyten. In 
hoofdstuk 5 is al aangetoond dat telling van deze cellen op problemen 
stuit. Andere merkstoffen zoals ontstekingseiwitten (bijvoorbeeld C-
reactief eiwit; CRP) zijn niet specifiek voor sepsis en kunnen  bij tal van 
andere ziekten een rol spelen. Andere specifieke eiwitten, zoals 
cytokines, zijn vaak moeilijk te meten en kosten veel geld. Geactiveerde 
granulocyten hebben een eiwit aan de buitenkant van de cel (CD64) dat 
dient om lichaamsvreemde stoffen te herkennen en ervoor te zorgen dat 
deze opgeruimd worden. Dit eiwit komt alleen voor op granulocyten die 
zijn geactiveerd door cytokines. In hoofdstuk 8 wordt een methode 
beschreven die het mogelijk maakt dat met een hematologie-automaat 
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(Cell Dyn 4000 met monoclonalenmodule) op eenvoudige en snelle wijze 
CD64 gemeten kan worden. 
Wat de rol van CD64 is in vergelijking met de andere sepsismerkstoffen 
wordt in hoofdstuk 9 beschreven. Hierbij is uitgegaan van een 
experimenteel sepsismodel waarbij proefpersonen endotoxine 
(lipopolysaccharide) ingespoten kregen en op verschillende tijdstippen 
bloed werd afgenomen. Hiervan werden tellingen verricht van de 
verschillende bloedcellen en werden cytokines en andere 
ontstekingseiwitten gemeten en de hoeveelheid CD64 bepaald. Hoewel 
cytokines als eerste stijgen blijkt ook CD64 snel te stijgen. De stijging 
van CD64 gaat geleidelijk en in twee fasen. De eerste fase loopt parallel 
aan de cytokines en de tweede fase loopt parallel aan het CRP.  Verder 
onderzoek moet uitwijzen of deze methode geschikt is als 
routinebepaling. De rol van CD64 is ook duidelijk gebleken bij ernstige 
sepsis met bacteriën in het bloed (bacteriëmie). In hoofdstuk 10 is een 
patiënt met een ernstige bacteriëmie beschreven. Bloed werd 
afgenomen en in het uitstrijkje waren microscopisch veel bacteriën te 
zien. Tevens is de CD64-activiteit gemeten en deze bleek zeer hoog te 
zijn. Ondanks het feit dat bacteriën in bloed een slecht vooruitzicht geeft 
(zie ook hoofdstuk 2), herstelde de patiënt goed. Dit kan erop wijzen dat 
een bacteriëmie in combinatie met een hoge CD64-activiteit een gunstig 
vooruitzicht heeft op genezing. 
 
 
reactie van granulocyten op endotoxinetoediening 
 
segmentkernige granulocyt 
 
staafkernige granulocyt 
 
 
segmentkernige granulocyt met CD64-activiteit 
 
staafkernige granulocyt met CD64-activiteit 
 
 
onrijpe granulocyt met CD64-activiteit 
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‘Soms zegt een blik in een bloeduitstrijkje meer dan uitslagen’, met een 
dergelijk betoog keek Cor van Oostrom regelmatig door de microscoop 
op het toenmalige Laboratorium Kindergeneeskunde, Afdeling Speciale 
Hematologie. Met die wijsheid heb ik destijds heel wat uitstrijkjes van 
bloed en beenmerg bekeken. De eerste stappen geleerd van Cocky 
Langenhuijsen die met kritische blik uitstrijkjes bekeek en vaak dingen 
zag waarvoor je een extra zintuig nodig had. Met dr de Vaan, 
kinderoncoloog, heb ik heel wat gezien. Hij was een vraagbaak van wie 
ik veel heb geleerd. Eén ding wisten alle wijzen niet: wat zijn toch die 
kleine op trombocyten lijkende dingen die je soms in bloed en beenmerg 
ziet. Een lange zoektocht begon en we kwamen uit bij zogenaamde 
lichaampjes van Hitmair, later bleken ze bekend onder de naam 
pseudoplaatjes. Als een rode draad koppelde dit fenomeen zich aan mijn 
morfologie-interesse en uiteindelijk resulteerde dit na jaren tot een artikel 
(hoofdstuk 7 in dit proefschrift) en kreeg het toch nog een rol in mijn 
onderzoek. Dr de Vaan zei onlangs nog: “blijf erin geloven, ook al heeft 
het bij anderen geen prioriteit.” En nog steeds geloof ik dat er te weinig 
aandacht is voor deze cytoplasmatische afsplitsingen. Morfologie is 
reuzenspannend: dr de Vaan, Cocky en Cor bedankt voor de basis. 
 
Verder gaat mijn dank uit naar iedereen die aan de totstandkoming van 
dit proefschrift een bijdrage heeft geleverd. Het is gevaarlijk om namen 
te noemen, maar toch zal ik een poging wagen. 
 
Als eerste wil ik noemen de collega’s van de Afdeling Klinische Chemie 
die zich vaak hebben afgevraagd: waar is hij toch mee bezig? Hopelijk is 
dat nu iets duidelijker. Jacqueline Dinnissen heeft een sleutelpositie 
ingenomen: loyaliteit, inzet en betrokkenheid bij de, soms tot niets 
leidende, hersenspinsels waren daarbij essentieel. 
 
Uiteraard bedank ik Hans Willems die mij de ruimte heeft gegeven te 
promoveren, wat niet zonder risico was. Er moest nog een ‘papiertje’ 
gehaald worden en wat gepubliceerd worden. Dat allemaal in een voor 
de afdeling hectische periode. 
 
Dank voor mijn co-promotoren Ries de Keijzer en Jacqueline Klein 
Gunnewiek. Jullie hulp, enthousiasme, geduld en het vermogen om mij 
weer met beide benen op de grond te plaatsen als ik weer eens een wild 
idee had. Om maar te zwijgen van al die taalcorrecties.  
 
Dorine Swinkels ben ik dank verschuldigd. Zij was als klinisch chemica in 
opleiding betrokken bij mijn eerste onderzoek waarbij zij me leerde om 
kritisch naar de resultaten te kijken en de onderzoeksopzet. Je was 
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enthousiast over ‘mijn’ pseudoplaatjes. We hebben tenminste 
geprobeerd er iets uit te halen. 
 
Ludi van Dun, van de firma Abbott, kwam ik ooit tegen op een 
symposium van de NVML (Utrecht 1997). Hij was geïnteresseerd in 
Diffex1 en vroeg of ik wat plaatjes wilde maken. Daaruit is een hecht 
contact ontstaan en daar waar mogelijk hebben we elkaar geholpen.  
 
A special word of thank for Steve Scott. You really deserve a statue! You 
gave me the opportunity to evaluate the CD3700 for the differentials. 
From that time we had a great cooperation. Four chapters in this thesis 
are a product of this cooperation! Without Steve this thesis could not 
exist at all. Breading hours and days on English texts to present data 
properly, Steve rewrote it in no time in real English. Steve, thank you 
very much for all your confidence in me! 
 
Jan van den Boogaart van de firma Bayer, wil ik graag bedanken. De 
vele trucjes die hij mij heeft geleerd om met de ADVIA 120 om te gaan 
heb ik vaak vergeten, maar telkens weer opnieuw werd het weer 
uitgelegd door Jan. 
 
Met de Sysmex NE-8000 begon mijn interesse in de automatische 
morfologie. Jan Willem Schipper en Paul Versteege beiden werkzaam bij 
Goffin Meyvis, en Jo Linssen van Sysmex Europe, wil ik graag bedanken 
voor het ontsluieren van de geheimen van de Sysmex NE-8000 en XE-
2100. Verdieping in de technologie van de hemocytometrie leidt tot een 
kritische kijk en onderzoek. 
 
Mijn paranimfen Irma en Erny, leuk dat jullie bereid waren om dingen te 
doen waarin ik zou falen. Bedankt! Vooral Erny, die het definitieve 
proefschrift nog eens minutieus heeft gecontroleerd. 
 
Lieve Ingrid, Tijs, Pim, Sjors en Jaap, jullie zijn mijn motivatie om de klus 
af te maken, bedankt voor jullie steun en vertrouwen. 
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